A Multidimensional Perspective Review of Traditional Chinese Medicine in Treating Ovarian Aging Authors: Wenjing Zhang, Ge Wang, Yingying Yan, Huanhuan Li, Shuang Li, Li Liu, Guanwei Fan Published: 2026 ABSTRACT AbstractOvarian aging represents a complex biological process involving the gradual decline of female reproductive system function, primarily manifested as diminished ovarian reserve, hormonal imbalance, and reduced fertility. This significantly impacts women’s health and quality of life. With increasing societal pressures and delayed childbearing trends in modern society, ovarian aging has become an increasingly prominent issue, necessitating effective intervention strategies. Traditional Chinese medicine, characterized by its multi-component, multi-target regulatory properties, has shown potential in alleviating ovarian functional decline, improving hormone levels, and delaying aging. This paper systematically summarizes the typical phenotypic characteristics of ovarian aging and its detection methods, reviews advances in animal model development and experimental techniques, and delves into the molecular mechanisms and key gene targets of traditional Chinese medicine regulation of ovarian aging. It focuses on evaluating the therapeutic effects and mechanisms of representative traditional Chinese herbs and formulas in improving ovarian function and delaying aging. By integrating the latest basic and clinical research findings, this paper aims to provide a scientific theoretical foundation and future research directions for traditional Chinese medicine treatment of ovarian aging, thereby contributing to the further development of traditional Chinese medicine in the field of female reproductive health.Keywords: ovarian aging, traditional Chinese medicine, pathological features, clinical phenotypes, animal models, mechanism of action Introduction Ovarian aging represents a progressive decline in female reproductive function, primarily characterized by a continuous reduction in the quantity and quality of oocytes within the ovaries. This physiological change triggers a series of external manifestations, specifically manifested as menstrual cycle irregularities, cessation of menstruation, and a significant reduction in fertility, greatly impacting women’s reproductive health and quality of life.1–3 Diminished Ovarian Reserve (DOR), Premature Ovarian Insufficiency (POI), and Premature Ovarian Failure (POF) all belong to the category of ovarian dysfunction. DOR is defined as a decrease in the number and/or quality of oocytes in the ovary, but the patient’s menstrual cycle usually remains regular, fertility is reduced but not lost, and there is no age limit. POI is a clear diagnosis based on clinical and endocrine indicators, which must meet the criteria of being under 40 years old, with menstrual abnormalities (infrequent or amenorrhea) accompanied by elevated levels of gonadotropins and decreased fluctuations in estrogen levels as the main clinical manifestations. POF traditionally refers to the end-stage failure of ovarian function, which is now commonly regarded as a severe late stage of POI, and the three have a causal and progressive relationship.4 With the acceleration of social rhythm and the intensification of environmental pollution, its incidence rate is on the rise and tends to be younger, which has become an important problem in the field of women’s health.5,6 Furthermore, the decline in estradiol (E2) levels significantly increases the risk of related diseases such as cardiovascular and cerebrovascular disorders, metabolic bone and joint diseases, neurological dysfunction, and disturbances in glucose and lipid metabolism.7 The etiology is complex and multifactorial, encompassing genetic predisposition, immune dysregulation, infections, and iatrogenic factors. However, among these numerous causes, the precise pathogenic mechanisms for most remain poorly elucidated.8 Modern medicine still faces many challenges in this field, mainly relying on hormone replacement therapy, ovulation induction measures, immune regulation interventions, mesenchymal stem cell transplantation technology, and gene therapy methods to alleviate clinical symptoms. Its safety and effectiveness need to be further improved.9 For patients with fertility aspirations, assisted reproductive technologies are employed to address reproductive challenges. However, these approaches face persistent issues including prolonged treatment cycles, potential side effects and limitations of therapeutic methods, and high recurrence rates after discontinuation. Consequently, there is an urgent need to develop safer and more effective treatment strategies.10,11 Traditional Chinese Medicine (TCM), as the core component of the Chinese traditional medical system, demonstrates significant therapeutic advantages in regulating ovarian function due to its unique pharmacological characteristics of multi-component synergy and multi-pathway integration. Fundamental TCM theory posits that “the kidneys store essence and govern reproduction,” with kidney deficiency being the fundamental pathogenesis underlying ovarian insufficiency. Combined with methods such as promoting blood circulation and removing blood stasis, TCM can holistically regulate the body’s state, improving ovarian microcirculation and endocrine function. For instance, traditional Chinese herbal formulas such as kidney-tonifying and blood-activating agents [eg, Yulin Decoction (Yùlín Tāng, a kidney-spleen tonifying herbal decoction for ovarian dysfunction), Guishen Pills (Guīshèn Wán, a spleen-kidney dual-tonifying herbal formula regulating ovarian endocrine function), Xianzi Yizhen Capsules (Xiānzǐ Yìzhēn Jiāonáng, a kidney-tonifying herbal capsule for improving ovarian reserve)] influence ovarian function by modulating multiple signaling pathways. They promote follicular development, inhibit granulosa cell apoptosis, and enhance blood circulation, thereby improving ovarian reserve and hormone levels.12–15 Furthermore, non-pharmacological TCM therapies like acupuncture and moxibustion have been demonstrated to improve neuroendocrine function, inhibit ovarian cell apoptosis, and promote ovarian function recovery.16–18 Modern research reveals that ovarian aging involves complex pathological mechanisms such as mitochondrial dysfunction, elevated oxidative stress levels, and imbalances in apoptosis and autophagy.19–21 Traditional Chinese Medicine exerts ovarian protective effects through multi-level mechanisms. For instance, at the neuroendocrine level, it precisely regulates the feedback loops of the hypothalamic-pituitary-ovarian (HPO) axis, restoring rhythmic gonadotropin secretion. At the tissue microcirculation level, it enhances ovarian blood perfusion by upregulating vascular endothelial growth factor (VEGF) expression while suppressing ovarian stromal fibrosis through downregulation of the transforming growth factor-β (TGF-β) signaling pathway; At the cellular protection level, it simultaneously inhibits granulosa cell apoptosis by activating the PI3K/Akt pathway, enhances the antioxidant defense system through the Nrf2/HO-1 pathway, and mitigates inflammatory cascades by regulating the NF-κB pathway. This multidimensional, multi-target integrated regulatory model suggests a promising therapeutic approach aligned with the TCM principle of “tonifying kidney essence to fortify the foundation and invigorating blood circulation to unblock meridians,” offering preliminary evidence and theoretical insights for delaying ovarian aging.22–24 Ovarian aging, a critical issue in female reproductive health, involves complex internal and external factors alongside multiple pathological mechanisms. Currently, Traditional Chinese Medicine, leveraging its systemic regulatory advantages, demonstrates broad application prospects in ovarian function preservation and premature ovarian aging treatment, with related basic and clinical research gradually expanding. This paper aims to systematically summarize the current research status of TCM in treating ovarian aging. From multidimensional perspectives including pathological mechanisms, phenotypic detection, animal models, molecular mechanisms, and therapeutic strategies, it comprehensively analyzes the action mechanisms and clinical potential of TCM in ovarian aging. This provides a crucial theoretical and practical foundation for developing safe and effective intervention strategies against ovarian aging. Research on Traditional Chinese Medicine Syndrome Differentiation and Modern Pathological Mechanisms of Ovarian Aging Classification of Traditional Chinese Medicine Syndrome Types for Ovarian Aging Although the pathogenesis of ovarian aging is complex in traditional Chinese medicine theory, its core lies in kidney deficiency, often accompanied by pathological changes such as spleen deficiency, blood stasis, and phlegm dampness. In clinical practice, corresponding treatment methods and prescriptions should be established based on different syndrome types. Kidney Deficiency Syndrome The kidneys are responsible for storing essence and reproduction, while the ovaries, as the core organ of female reproduction, are directly nourished and regulated by the essence and qi of the kidneys. Kidney deficiency syndrome can be divided into two core types in ovarian aging: kidney yin deficiency syndrome and kidney yang deficiency syndrome. Kidney yin deficiency and yin deficiency can generate internal heat, which can disturb the uterus and accelerate follicular atresia, leading to premature ovarian failure; If the kidney yang is deficient and the yang qi is insufficient, then impaired warming function may lead to delayed circulation of qi and blood, delayed follicular development, and ovulation disorders, which can also cause ovarian function decline. Clinical traditional Chinese medicine interventions often use classic kidney tonifying formulas such as Zuogui Pill (ZGP, Zuǒguī Wán, a classic kidney-yin nourishing herbal formula to improve ovarian reserve), Yougui Pill (YGP, Yòuguī Wán, a representative formula for warming and tonifying kidney yang), and Yulin Decoction as the core basic formulas. Based on this, the core treatment principles of tonifying kidney and qi, filling the marrow and replenishing essence, and regulating Chong Ren can be established, which are in line with the core medical pathogenesis of ovarian aging, such as kidney deficiency, essence deficiency, and Chong Ren imbalance. Spleen Deficiency Syndrome In the TCM syndrome differentiation and treatment system, besides kidney deficiency as the core pathogenesis, spleen deficiency with impaired transportation is also a crucial pathogenic factor in ovarian aging. If the spleen deficiency and weak qi, as well as the loss of circulation and metabolism, are caused by irregular diet, excessive fatigue, worrying about damaging the spleen, or long-term illness and lack of nourishment, it will lead to a series of symptoms related to ovarian function decline. Clinically, Shenling Baizhu San (Shēnlíng Báizhú Sǎn, a classic traditional Chinese medicine formula for nourishing the spleen and stomach and enhancing physical fitness) is often used as the basic formula for differential diagnosis and adjustment intervention, aiming to restore normal spleen and stomach function, nourish the source of qi and blood formation, and improve ovarian reserve function. Cold Coagulation and Stasis Syndrome Ovarian aging can be caused by invasion of cold pathogenic factors, stagnation of qi and blood, and obstruction of the Chong and Ren meridians. The core pathogenesis is that cold pathogenic factors affect the Chong and Ren meridians, leading to stagnation of qi and blood, loss of nourishment in the uterus, and ultimately causing ovarian function decline and a series of clinical symptoms. Cold coagulation and blood stasis syndrome is one of the important types of ovarian aging, represented by the formulas Guizhi Fuling Pill (Guìzhī Fúlíng Wán, a classic herbal pill activating blood circulation to alleviate ovarian pathological damage) and Yulin Zhu. Clinical treatment is based on the core principles of warming the meridians, dispersing cold, promoting blood circulation, and removing blood stasis, while also taking into account warming and tonifying yang qi, in order to restore the smoothness of the Chong and Ren meridians and ovarian function, and improve ovarian blood flow perfusion. Qi Stagnation and Blood Stasis Syndrome Qi stagnation, Qi stagnation with blood stasis, and Chong Ren stagnation are important types of empirical pathogenesis, often caused by emotional disorders and prolonged liver qi stagnation, ultimately leading to ovarian dysfunction, menstrual disorders, and systemic emotional symptoms. The liver plays a crucial role in regulating the physiological functions of the ovaries and uterus by regulating the flow of qi throughout the body. If there is long-term emotional instability, it can lead to liver qi stagnation, qi stagnation resulting in blood stasis, blood stasis blocking the Chong and Ren meridians, and inability to distribute qi and blood to the ovaries. This syndrome is closely related to neuroendocrine network disorders and ovarian microcirculation disorders, especially the effect of hormone level changes on the reproductive axis. Traditional Chinese medicine treatments such as Erzhi Tiangui Decoction (Èrzhì Tiānguǐ Tāng, a liver-kidney essence-nourishing herbal formula for delaying ovarian aging) and Zhibai Dihuang Pill (Zhībǎi Dìhuáng Wán, a traditional Chinese patent medicine and simple preparation that can nourish yin and clear away heat. It can treat the decline of ovarian reserve function mainly focus on promoting qi circulation and blood circulation, dispelling blood stasis and promoting meridian circulation. By unblocking the qi flow and resolving blood stasis, breaking the vicious cycle of “qi stagnation→blood stasis”, improving local microcirculation of the ovary, and promoting follicle development and ovulation. The distribution pattern of the above syndrome types is deeply related to the pathological mechanism of ovarian aging. Kidney deficiency is essentially the expression of traditional Chinese medicine syndrome with dysfunction of the HPO axis and depletion of the primordial follicle pool; Liver depression corresponds to endocrine disorders and HPO axis inhibition; Blood stasis corresponds to ovarian microcirculation disorders and tissue fibrosis. This correspondence between “pathogenesis-syndrome-pathology correlation” provides a theoretical basis for subsequent correlation analysis between traditional Chinese medicine syndrome types and specific molecular signaling pathways. Modern Pathological Mechanisms of Ovarian Aging Ovarian aging represents a complex biological process influenced by multiple factors and involving several interconnected stages. Its core pathological mechanisms primarily manifest as an irreversible reduction in follicular reserve and a progressive, sustained decline in oocyte quality. This process is driven by multiple pathological mechanisms at cellular and molecular levels. Follicular quantity is primarily regulated by genetic factors and endocrine hormones, while follicular quality decline is associated with oxidative stress, mitochondrial dysfunction, alterations in telomeres and telomerase, and vascular factors. These factors ultimately lead to a progressive reduction in follicular developmental potential and oocyte quality (Figure 1). Various factors leading to ovarian aging. This diagram centers around a healthy ovary and elucidates the multifactorial regulatory mechanism of ovarian aging: genomic instability and epigenetic alterations, mitochondrial dysfunction, enhanced oxidative stress, imbalance between apoptosis and autophagy, and microenvironment aging collaboratively contribute to follicular depletion and drive the ovarian aging process through DNA mutation damage, telomere/telomerase abnormalities, mitochondrial DNA mutations and functional decline, excessive reactive oxygen species-induced macromolecular damage and abnormal apoptosis, autophagy disorder, and inflammation and vascular endothelial dysfunction mediated by aging-related secretory phenotypes, as well as tissue fibrosis. The arrows between the modules in the figure indicate causal relationships or promoting directions: the starting point of the arrow has a positive regulatory or inducing effect on the ring it belongs to. In the figure, “↑” indicates an increase/increase in the indicator or process, while “↓” indicates a decrease/decrease. Genomic Instability and Epigenetic Alterations Genomic DNA Mutations and Damage Female ovarian function relies on two structurally normal X chromosomes. Key genes associated with ovarian development and function are concentrated in the POF1 (Xq26-q28) and POF2 (Xq13-q21) regions of the X chromosome. These genes are crucial for ovarian development and function; their mutations lead to premature ovarian failure in females.25 The genetic etiology of premature ovarian failure involves numerical and structural abnormalities of the X chromosome, constituting the key genetic factors triggering this condition. These manifest in several typical scenarios: Turner syndrome, X trisomy, microdeletions of Xp or Xq, and fragile X syndrome.26–28 Beyond DNA mutations, endogenous byproducts generated by cellular metabolic activities and various environmental toxins continuously damage oocyte DNA as individuals age. Among these damage types, DNA double-strand breaks (DSBs) pose the most significant threat. When the body has X-linked gene defects, it directly causes a significant decrease in the expression of DNA double strand break repair related proteins such as breast cancer 1 (BRCA1) and Meiotic Recombination 11 Homolog A (MRE11) in oocytes. Insufficient repair proteins can significantly weaken the DNA damage repair efficiency of oocytes, making it difficult to timely clear and continuously accumulate DNA double strand breaks, leading to oocyte aging.29 Conversely, the oocyte’s inherent DNA damage repair capacity also diminishes progressively with age. Additionally, with reproductive aging, meiosis in oocytes undergoes chromosomal misalignment and unequal segregation. During this specialized process, the function of the spindle assembly checkpoint weakens, likely contributing to an increased risk of chromosomal misseparation and aneuploidy. This risk is the direct cause of the significantly elevated aneuploidy rate in embryos from older women.30,31 Cohesin, a crucial protein family, plays a vital role in precisely regulating the connection status and separation process of sister chromatids during mitosis and meiosis. It is primarily composed of Meiotic Recombination Protein 8 (Rec8), Stromal Antigen 3 (STAG3), Structural Maintenance of Chromosomes 1B (SMC1β), and Structural Maintenance of Chromosomes 3 (SMC3) proteins.32 Studies have shown that, in the eggs of aging mice, long-term and sustained genome damage will further induce the degradation of mucin Rec8 and SMC1β, and Rec8 is the core protein that maintains the stable binding of meiotic sisters chromatids. After Rec8 depletion, the sisters chromatids lose their stable anchoring structure, which is prone to chromosomal disorder and unequal separation during meiosis, thus forming aneuploid oocytes and embryos. Oocytes with chromosomal abnormalities will experience developmental arrest and activate the apoptosis program, ultimately leading to follicular atresia.33 Consequently, cohesin is strongly associated with premature chromosome separation and aneuploidy, negatively impacting female reproductive function and ultimately leading to diminished fertility. Epigenetic Influences on Ovarian Aging Epigenetic remodeling also plays a pivotal role in the process of ovarian aging. Epigenetic regulatory mechanisms encompass multiple aspects, including DNA methylation, histone modifications, and non-coding RNA expression. These regulatory approaches enable precise control over gene expression patterns without altering the DNA sequence itself. In aged ovarian tissue, the levels of DNA methyltransferases (DNMTs), enzymes responsible for adding methyl groups to DNA, gradually decrease with age. Conversely, the levels of DNA demethylases (TET), enzymes that remove methyl groups from DNA, show an upward trend. This enzymatic shift ultimately reduces overall DNA methylation levels in oocytes, contributing to ovarian aging.34 Studies using TET enzyme knockout mouse models of premature reproductive failure revealed that Tet1 gene knockout (Tet1-/-) disrupts normal expression of genes involved in organelle fission pathways and retrotransposon regulation pathways.35 Tet1-/- mice exhibited downregulation of Fmr1, a key gene associated with premature ovarian failure. Reduced Fmr1 expression directly caused a decrease in follicle numbers. As follicles are the fundamental units of reproductive function, this sharp reduction ultimately induced POF, significantly impairing reproductive capacity in mice. This demonstrates that Tet enzymes can regulate premature aging of the reproductive system through epigenetic mechanisms. Additionally, modifications such as acetylation and methylation occurring on histones also undergo significant alterations, which further influence gene transcription activity. Throughout the series of processes involved in the normal development and maturation of oocytes, histone modification states exhibit dynamic changes. Specifically, in oocytes at the germinal vesicle stage (GV stage), acetylation occurs at lysine residues 12 (H4K12) and 16 (H4K16) of histone H4. This modification is crucial for the normal development of GV-stage oocytes. As oocytes progress into meiosis I (MI) and meiosis II (MII), histone deacetylases (HDACs) act to deacetylate H4K12 and H4K16, thereby maintaining the dynamic equilibrium of histone modifications during oocyte development.36 However, with advancing age, acetylation levels of H4K12 and H4K16 decrease in aged GV oocytes. Defective H4K12 deacetylation occurs during MII, and excessive histone acetylation in MII oocytes leads to increased aneuploidy and post-fertilization embryonic death.37,38 These cumulative epigenetic alterations disrupt normal gene expression programs in oocytes, impairing their ovarian developmental potential. Furthermore, abnormalities in DNA methylation sites can trigger the initiation of apoptosis and accelerate cellular aging processes. As the fundamental functional units constituting the ovary, the increased rates of apoptosis and aging in these cells accelerate the overall aging trajectory of the ovarian tissue. Changes in Telomeres and Telomerase Telomeres are located at the ends of eukaryotic chromosomes. Composed of multiple DNA repeat sequences (TTAGGG)_n and telomere-associated proteins, they effectively shield chromosome ends from various damaging factors, thereby maintaining the overall stability and integrity of the genome. During biological processes, telomere length gradually shortens with each cell division due to external influences such as DNA replication and oxidative stress responses. Consequently, telomere length is considered closely linked to human aging. Telomere shortening also leads to instability in the terminal sequences of chromosomes, activating DNA damage signaling mechanisms. These signaling pathways cause oocyte cell cycle arrest, ultimately driving them toward apoptosis.39 Concurrently, telomerase is a crucial factor in maintaining telomere length and chromosomal stability. Follicular development relies on telomerase regulation. During female physiological changes, telomerase activity in the ovaries declines with age. Reduced telomerase activity further leads to diminished follicular quality and female infertility. This indicates a correlation between ovarian follicular reserve and telomerase activity.40 In aging ovarian tissue, abnormalities in oocyte meiosis are particularly common. When telomere function is compromised, it significantly reduces the efficiency of recombination during meiosis, leading to errors in chromosome segregation and even chromosomal loss.41 Further investigation reveals that telomere shortening also decreases the frequency of synapsis between homologous chromosomes and the number of crossovers formed during meiosis. These alterations induce abnormalities in oocyte meiosis, including disorganized chromosome alignment at metaphase and defects in spindle dynamics.42 Such anomalies ultimately result in a substantial decline in egg quality. Consequently, telomere function plays a critically important role in enabling germ cells to complete normal meiosis. Telomeres are crucial for female reproductive capacity, and measuring telomere length and determining telomerase activity serve as key indicators for assessing germ cell quality. From the cutting-edge perspective of telomere regeneration, utilizing pluripotent stem cell technology to restore telomere length and telomerase activity in reborn oocytes may offer a highly promising breakthrough approach for intervening in ovarian aging. Mitochondrial Dysfunction Mitochondria are hailed as the “powerhouses” of cells, playing an irreplaceable and pivotal role in oocyte maturation and early embryonic development.43 The distribution density of mitochondria within oocytes ranks highest among all human cell types. These mitochondria continuously supply ample ATP to vital processes during oocyte meiosis, including spindle assembly, chromosome separation, and cellular maturation, ensuring the smooth progression of all life activities.44 Mitochondrial dysfunction is a core factor in reduced oocyte quality and is closely linked to ovarian aging.45 The impact of aging factors on mitochondria manifests in two primary ways. First, aging induces mutations in mitochondrial DNA (mtDNA) while simultaneously reducing mtDNA copy numbers.46 Since mtDNA lacks the stringent protection afforded by histones and possesses inherently limited repair mechanisms, it is highly susceptible to external damage. Mutations in mtDNA disrupt the normal physiological function of the oxidative phosphorylation chain complex, thereby impairing energy production. On the other hand, aging also induces morphological and functional abnormalities in mitochondria within oocytes.47 This manifests as reduced mitochondrial membrane potential, insufficient ATP synthesis to meet cellular demands, and fragmentation or disorganization of internal cristae structures. These dysfunctional mitochondria fail to provide adequate energy support for meiosis and embryonic development. In the context of reproductive aging, senescent oocytes exhibit pronounced energy metabolism abnormalities. This manifests as significantly reduced intracellular ATP production and overall diminished metabolic activity. Such metabolic alterations in turn impair meiosis spindle assembly, cell cycle regulation, chromosome segregation, and embryonic development, potentially leading to post-implantation miscarriage.44 During reproductive aging, granulosa cells also exhibit high levels of mtDNA deletions and impaired mitochondrial function. These mtDNA deletions and mitochondrial dysfunction disrupt communication between granulosa cells and oocytes, thereby hindering oocyte maturation and accelerating ovarian aging.48 Elevated Oxidative Stress Levels The pivotal role of free radicals has been extensively studied across various diseases and is recognized as a key mechanism in ovarian aging. Cells continuously generate reactive oxygen species (ROS) during aerobic metabolism. In young, healthy cells, ROS production maintains a dynamic equilibrium with the endogenous antioxidant system.23 When this equilibrium is disrupted, the body’s efficiency in scavenging free radicals significantly declines. Free radicals cannot be cleared promptly and effectively, leading to substantial accumulation within the body. When the accumulation of free radicals exceeds the body’s regulatory capacity, it triggers an oxidative stress (OS) response. Among the numerous factors contributing to diminished oocyte quality, natural aging is considered a major contributing factor. Natural aging is closely linked to elevated oxidative stress levels in oocytes. As oocytes and granulosa cells age, antioxidant gene expression decreases, increasing ovarian OS. This leads to DNA damage and apoptosis, disrupting intracellular homeostasis and negatively impacting oocyte quality, ultimately impairing ovarian function.49 This imbalance between ROS production and clearance causes ROS to accumulate extensively within cells. Excessive ROS can cause oxidative damage to intracellular biomolecules such as proteins and lipids. It attacks intracellular lipid components, triggering lipid peroxidation reactions that disrupt the integrity of cell membrane structures, impairing normal functions like substance transport and signal transduction in oocytes. Simultaneously, ROS damages proteins, causing them to lose their original biological activity or leading to abnormal protein aggregation and precipitation, which interferes with normal physiological activities within cells and results in impaired ovarian function. Furthermore, ROS damage to nucleic acids cannot be overlooked, as it exacerbates genomic instability and increases the risk of genetic mutations.23,50,51 In oocytes, high concentrations of ROS exert more direct and severe effects. They impair the normal assembly of the spindle apparatus, leading to chromosomal abnormalities during segregation and resulting in the misdistribution of genetic material carried by the oocyte. Moreover, high concentrations of ROS can also promote the opening of the mitochondrial permeability transition pore, which initiates the apoptosis program within the cell and drives oocytes towards apoptosis.44 Thus, it can be seen that oxidative stress is a key driving factor that accelerates the loss of oocytes in terms of both quality and quantity. Imbalance of Apoptosis and Autophagy Follicular atresia represents the natural degeneration of ovarian follicles that fail to mature or complete ovulation, ultimately undergoing apoptosis. As the ovaries enter the aging phase, the regulatory network governing apoptosis becomes severely disrupted.52 Various stress factors mentioned above—including genomic damage, telomere shortening, mitochondrial dysfunction, and oxidative stress—trigger apoptosis. This apoptotic process primarily involves granulosa cells and oocytes within the ovary. Granulosa cells serve as the core functional cells within follicles, surrounding the oocyte and providing essential support and nutrition during follicular development and maturation. The oocyte itself constitutes the central germ cell. Their apoptosis severely disrupts normal follicular development and maturation, accelerating overall ovarian functional decline.53 Unlike apoptosis, autophagy represents a conserved physiological process of cellular self-digestion, exerting complex “double-edged sword” effects within ovarian tissue. Under basal conditions, autophagy serves as a key mechanism for intracellular quality control. During cellular homeostasis, it efficiently removes damaged proteins and dysfunctional organelles. When cells face energy stress, it also provides essential nutrients, playing an irreplaceable role in maintaining the structural integrity and functional stability of oocytes. However, during ovarian aging, autophagy function may become disrupted. On one hand, reduced efficiency of the autophagic-lysosomal pathway impedes mitophagy, leading to abnormal accumulation of dysfunctional mitochondria and misfolded proteins in the cytoplasm. This activates the Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase system, triggering oxidative damage and ultimately disrupting cellular metabolic functions.54 On the other hand, under certain sustained stress conditions, overactivated autophagy may directly induce cell death.55 This imbalance in bidirectional regulation transforms autophagy from a protective mechanism into a driver accelerating tissue aging, with its dynamic equilibrium directly determining the duration of ovarian reserve function maintenance. Notably, autophagy and apoptosis pathways exhibit multidimensional cross-regulation: autophagy suppresses apoptotic signaling by clearing damaged mitochondria, while apoptosis-related proteases conversely regulate the cleavage modification of key autophagy proteins. This antagonistic yet synergistic regulatory network collectively establishes a finely tuned control system for cell fate determination during the follicular development cycle, playing a crucial role in sustaining female ovarian function. The Ovarian Microenvironment Influences Ovarian Aging The ovarian microenvironment, as a highly complex dynamic regulatory system, is jointly constructed by germ cells, somatic cells, extracellular matrix, and signaling molecules (including endocrine hormones, paracrine growth factors, and metabolic intermediates). Intercellular communication occurs through direct contact mediated by membrane surface receptors or paracrine signal transduction.56 These interactions influence oocyte quality maintenance, and microenvironmental imbalances can accelerate germ cell aging. Bidirectional signaling regulation between oocytes and somatic cells occupies a central role in the reproductive cycle. Cumulus cells provide essential nutritional support for oocyte meiotic recovery and cytoplasmic maturation through diverse paracrine signaling pathways. Imbalances in the dynamic equilibrium between synthesis and degradation of extracellular matrix components affect tissue structure and function; excessive deposition can trigger tissue fibrosis. Experimental evidence demonstrates a positive correlation between fibrosis levels in mouse ovarian stroma and reproductive age, with this pathological change serving as an early biological marker of ovarian stromal aging.57 Ovarian tissue is functionally divided into two major regions: the cortex and the medulla. The medulla primarily consists of connective tissue, collagen fiber networks, and vascular systems. Under normal physiological conditions, the active proliferation of ovarian vascular endothelial cells provides ample oxygen, nutrients, and signaling molecules for follicular development. Concurrently, these endothelial cells secrete bioactive molecules such as vascular endothelial growth factor and nitric oxide via paracrine mechanisms, precisely regulating granulosa cell proliferation and differentiation, oocyte maturation, and corpus luteum formation to maintain ovarian function.58 During ovarian aging, significant alterations occur in tissue structure and function. Vascular endothelial dysfunction leads to abnormally elevated endothelial permeability, allowing inflammatory cytokines (eg, IL-6, TNF-α) and oxidative stress products (eg, reactive oxygen species, ROS) to leak into the ovarian stroma. This triggers progressive fibrosis of the stroma, further disrupting the ovarian microenvironment homeostasis.59 Concurrently, during vascular aging, endothelial cells release substantial amounts of senescence-associated secretory phenotype (SASP) factors. These factors exert paracrine effects on ovarian granulosa cells and theca cells, accelerating depletion of the ovarian follicular pool and diminishing reproductive function.60 Thus, the ovarian microenvironment plays a pivotal role in ovarian aging. Phenotypic Characteristics and Clinical Detection Methods of Ovarian Aging Phenotypic and Histological Features of Ovarian Aging Ovarian aging represents the physiological process of gradual decline in female reproductive function. Its clinical manifestations and histological features exhibit multidimensional changes, reflecting diminished ovarian reserve and altered endocrine environments. First, regarding indicators of ovarian reserve function, anti-Müllerian hormone (AMH) serves as a key biomarker reflecting functional ovarian reserve. AMH levels are closely linked to the number of follicles within the ovaries and the active degree of follicular development.61 Its serum levels exhibit a negative correlation with female age, meaning AMH levels decline progressively with advancing age. Declining AMH levels indicate diminished ovarian fertility, often accompanied by reduced follicle count and abnormal follicular development. Studies demonstrate that AMH measurement can detect ovarian function changes early in the aging process. Precise assessment of AMH levels provides a scientific and reliable basis for formulating clinical treatment plans, thereby effectively enhancing the success rate and safety of assisted reproductive therapies.62,63 Hormonal alterations constitute another critical clinical manifestation of ovarian aging. Follicle-stimulating hormone (FSH), secreted by the pituitary gland, is regulated by hypothalamic gonadotropin-releasing hormone and ovarian estradiol (E2). FSH promotes follicular maturation, and its elevation indicates ovarian insufficiency.64 As ovarian function declines, the body’s endocrine balance is disrupted.FSH levels gradually rise while estrogen levels decrease, leading to menstrual cycle irregularities in women. Specifically, the increase in FSH levels stems from disruption of the negative feedback regulation mechanism within the hypothalamic-pituitary-ovarian axis.65 Under normal physiological conditions, estrogens and progesterones secreted by the ovaries exert negative feedback regulation on the hypothalamus and pituitary gland to maintain relatively stable hormone levels. However, when ovarian function declines, its sensitivity to gonadotropin stimulation significantly decreases, weakening negative feedback regulation and consequently leading to increased FSH secretion by the pituitary gland.66 Concurrently, reduced E2 levels directly affect endometrial tissue, disrupting normal endometrial growth, differentiation, and shedding processes, thereby undermining the inherent regularity of the menstrual cycle.67,68 Clinically, menstrual cycle disorders manifest as oligomenorrhea, amenorrhea, or irregular bleeding. These symptoms serve as critical indicators of ovarian insufficiency, prompting comprehensive and detailed assessment and diagnosis of ovarian function to enable timely intervention. Such measures aim to delay ovarian aging and improve reproductive health outcomes.69,70 Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) synergistically play crucial roles. LH interacts with receptors on follicles, promoting their gradual maturation.71 This process involves a series of complex physiological and biochemical reactions. LH acts on G protein-coupled receptors within the follicle, thereby promoting follicular cell proliferation and differentiation, as well as the synthetic and secretory functions of granulosa cells, creating the necessary conditions for the follicle’s ultimate maturation.72,73 During the normal reproductive physiological cycle, the hypothalamic-pituitary-ovarian axis maintains relatively stable hormone levels through a precise negative feedback regulatory mechanism. As ovarian aging progresses, ovarian tissue becomes less sensitive to LH and FSH, leading to impaired follicular development and impaired ovulation. This, in turn, causes the hypothalamus and pituitary gland to continuously secrete LH and FSH, ultimately resulting in elevated levels of these two hormones in the blood. This change reflects the decline in ovarian function. Inhibin B (INHB) is a glycoprotein hormone secreted by ovarian granulosa cells of the follicular phase. Its primary function is to negatively regulate pituitary secretion of FSH, thereby participating in the regulation of follicular development and the menstrual cycle.74 As the ovaries enter the aging phase, the gradual reduction in follicle numbers and the decline in follicular development function lead to a corresponding decrease in the ability of theca-interstitial cells to synthesize and secrete INHB. Consequently, its concentration in the blood shows a downward trend, providing valuable reference data for the clinical assessment of ovarian function.75 In addition to other commonly used indicators, progesterone (P4) is occasionally included as one of the markers for assessing ovarian function. The physiological function of P4 is closely linked to the ovulation process and corpus luteum function in women. As women age, ovarian function gradually declines, characterized by reduced follicle numbers and diminished quality, abnormal ovulation, poor corpus luteum formation, or luteal insufficiency. These factors collectively lead to decreased progesterone secretion, resulting in lower overall progesterone levels in the body.76 From a histological perspective, ovarian aging manifests as follicular atrophy, fibrosis of the ovarian stroma, and increased cellular apoptosis. Follicular atrophy leads to a significant reduction in the number of actively developing follicles within the ovary. In the female reproductive cycle, active follicles are crucial for maintaining normal reproductive function. Their depletion signifies a decline in ovarian reserve. Fibrosis of the ovarian stroma reflects the remodeling and hardening of the ovarian matrix, negatively impacting blood supply and the internal microenvironment, thereby limiting ovarian function.59 During ovarian aging, characteristic changes also occur in its microvasculature, primarily manifested as a gradual reduction in vessel number, remodeling of vessel wall structure, and even sclerosis.76,77 This leads to a sharp decline in ovarian blood perfusion, resulting in tissue ischemia. The degeneration of the vascular system not only exacerbates follicular apoptosis and stromal fibrosis but also accelerates the decline in ovarian function.78 Abnormally elevated levels of apoptosis are particularly prominent during ovarian aging. Characterized by features such as upregulation of p53 expression and a reduced Bcl-2 to Bax ratio, these changes collectively activate intrinsic apoptotic signaling pathways, triggering the death of granulosa cells and oocytes. This accelerated apoptotic process is the direct cause of premature depletion of the follicular reserve. Related studies indicate that environmental factors such as endocrine disruptors can accelerate ovarian aging by inducing ovarian cell apoptosis and fibrosis.79 Furthermore, in aged ovarian tissue, cellular senescence phenotypes exhibit a trend of continuous accumulation.80,81 For instance, the positive staining reaction of Senescence-Associated β-galactosidase (SA-β-Gal), a classic biological marker of cellular senescence, shows a significant positive correlation with declining ovarian reserve function.82 Simultaneously, the expression of γ-histone H2A variant X (γ-H2A.X), a DNA damage repair-associated histone variant and aging biomarker, is upregulated, directly reflecting genomic damage and suggesting a pivotal role for cellular senescence in ovarian tissue degeneration.83 In summary, the clinical manifestations of ovarian aging primarily include decreased anti-Müllerian hormone, elevated follicle-stimulating hormone, reduced estrogen levels, and menstrual cycle irregularities. Histological features encompass follicular atrophy, stromal fibrosis, and increased apoptosis. These interrelated changes collectively lead to progressive ovarian functional decline. Future research should integrate molecular genetics, environmental factors, and cellular biological mechanisms to deepen understanding of the multidimensional phenotype of ovarian aging, thereby advancing precision diagnosis and personalized treatment (Figure 2A). Overview of clinical assessment and experimental research methods for ovarian aging. (A) illustrates the phenotypic characteristics and clinical detection methods of ovarian aging, including ovulation disorders, changes in hormone levels (FSH, AMH, etc.), and histological features (follicular atresia, stromal fibrosis, etc.). Detection methods encompass biochemical indicator testing, ultrasound evaluation, molecular biology analysis, and functional dynamic testing. A1: Macroscopic phenotype and histopathological changes of ovarian aging A2: Clinical detection techniques and commonly used indicators for ovarian aging. (B) introduces the construction of animal models for ovarian aging and experimental methods, using mice, rats, Guinea pigs, and non-human primates as commonly used model animals. These models include natural aging, drug-induced, surgical, and genetically engineered models. Research is conducted through assessments of reproductive function and estrus cycle, endocrine testing, histomorphological analysis, and cell and molecular biology techniques, providing a systematic clinical and experimental research framework for ovarian aging research. B1: Selection of Animal Models for Ovarian Aging. B2: Classification of Animal Models of Ovarian Aging. B3: Experimental evaluation and detection methods for ovarian aging research. Functional biomarkers such as AMH and menstrual cycle changes often appear before histological changes. AMH can detect abnormalities several years before significant decline in ovarian reserve, while follicular atrophy and interstitial fibrosis are irreversible end-stage changes, providing a critical time point for early targeted interventions for ovarian aging in clinical practice. However, the current phenotype evaluation system has limitations. Markers such as AMH, FSH, AFC, etc. can only inform the current stock of follicles, but cannot predict the rate of follicle depletion, nor can they distinguish between the two fundamentally different degradation modes of “physiological slow aging” and “pathological rapid failure”. Although aging markers such as SA-β-Gal and γ-H2A.X can partially reflect the accumulation of cellular damage, their detection relies on ovarian tissue samples and is difficult to promote in clinical practice. Future research can establish a dynamic monitoring system that tracks the rate of AMH decline in individuals longitudinally over a long period of time. By integrating multiple omics features and artificial intelligence algorithm models, an individualized ovarian aging trajectory prediction model can be constructed to ultimately upgrade the clinical paradigm from “static stage state assessment” to “dynamic trend accurate prediction”. At the same time, multidimensional research evidence from molecular genetics, environmental factors, and cellular aging molecular mechanisms can be further integrated to deepen the systematic understanding of the multidimensional heterogeneity phenotype of ovarian aging, providing core theoretical support for the precise classification diagnosis of ovarian aging related diseases and the development of individualized intervention strategies. Modern Diagnostic Methods for Ovarian Aging Modern medicine offers increasingly diverse approaches to detecting ovarian aging, encompassing biochemical marker testing (quantitative measurement of anti-Müllerian hormone, follicle-stimulating hormone, estradiol, etc)., high-resolution ultrasound imaging assessment (3D ovarian volume measurement and antral follicle count), molecular biology techniques (metabolomics analysis and DNA methylation clock analysis), and dynamic ovarian reserve function tests (clomiphene stimulation test and GnRH agonist stimulation test). By integrating static biomarker data with dynamic functional assessment, these methods provide a comprehensive reflection of ovarian function status and its aging progression. Biochemical Marker Testing Serum Hormone Levels Biochemical indicators testing is an important method for evaluating ovarian reserve function, mainly including the determination of hormone levels such as AMH, FSH, and E2. AMH, as a direct reflection of ovarian reserve function, is closely related to the number of antral follicles and can indicate early decline in ovarian function. FSH and E2 reflect the regulatory status of the pituitary ovarian axis, with an increase in FSH and a decrease in E2 commonly occurring during the stage of ovarian dysfunction. In experiments treating ovarian aging with TCM compounds, ELISA detected increased traditional Chinese medicine can increase serum AMH and E2 levels, and reduce FSH levels, indicating that traditional Chinese medicine has a positive effect on hormone regulation in the body.84 Inflammatory Cytokine Levels Inflammatory responses play a pivotal role in the progression of ovarian aging and its associated diseases. Inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) exhibit significantly elevated expression levels during ovarian aging and related pathological states. These inflammatory mediators participate in and trigger inflammatory responses, further exacerbating ovarian tissue damage and disrupting the ovarian microenvironment balance.85,86 Multiple traditional Chinese medicine formulations have demonstrated promising efficacy in suppressing inflammatory responses. These herbs effectively block the transmission of inflammatory signaling pathways, reduce IL-6 and TNF-α expression levels, thereby alleviating ovarian inflammation, improving the ovarian microenvironment, and creating favorable conditions for ovarian tissue repair and functional recovery.87 Compared to reproductive hormones, inflammatory factors such as TNF-α and IL-6 are only secondary markers associated with ovarian aging and do not have specificity. Elevated levels alone cannot distinguish between ovarian inflammation and systemic chronic inflammation, and can only be used as auxiliary efficacy evaluation indicators. They cannot be used alone for the diagnosis of ovarian aging. Oxidative Stress Levels In the treatment of ovarian aging with Chinese herbal medicine, enhanced antioxidant capacity and regulated inflammation levels are two key assessment indicators. Multiple studies indicate that as ovarian function gradually declines, the body’s internal oxidative stress state undergoes significant alterations. Specifically, oxidative stress levels rise sharply, while the activity of antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) shows a marked downward trend. This shift leads to excessive accumulation of reactive oxygen species (ROS) within the body, which cannot be cleared efficiently and promptly. Excessive ROS severely damages ovarian tissue and oocyte function, disrupting their normal physiological structure and function, thereby accelerating the aging process of the ovaries.88,89 Traditional Chinese medicine formulas such as Zuogui Pill can significantly enhance the activity of SOD and GSH-Px, and improve the body’s ability to clear reactive oxygen species; At the same time, it can also reduce the accumulation of lipid peroxidation products malondialdehyde (MDA) and ROS, thereby alleviating oxidative damage and restoring ovarian function.90 TCM exerts a dual-mechanism effect through antioxidant and anti-inflammatory actions, effectively mitigating oxidative stress damage and inflammatory injury associated with ovarian aging. These mechanisms serve as key indicators for evaluating therapeutic efficacy and represent important therapeutic targets. Apoptosis and Autophagy Levels Apoptosis and autophagy play crucial roles in ovarian aging and related pathological processes. Apoptosis-related proteins in ovarian tissue, such as the pro-apoptotic factor Bax and the executioner caspase-3, are significantly upregulated during aging and injury. This leads to massive apoptosis of follicular and granulosa cells. The extensive cell death directly causes a decline in ovarian reserve function, impairs normal reproductive function, and reduces female fertility.80 Traditional Chinese herbal formulas demonstrate unique regulatory effects on these apoptotic pathways. Classic formulas such as Danggui Buxue Tang (Dāngguī Bǔxuè Tāng, a classic qi-blood tonifying herbal decoction for improving ovarian endocrine function), Chaihu Shugan San (Cháihú Shūgān Sǎn, a liver-regulating traditional Chinese herbal powder), and Zuogui Pill have been reported to inhibit the expression of pro-apoptotic proteins Bax and caspase-3, possibly through modulation of the ratio of Bcl-2 family proteins. Simultaneously, they promote the upregulation of pro-apoptotic proteins Bcl-2, significantly reducing ovarian cell apoptosis rates. This provides effective protection for ovarian function, maintaining normal physiological states.91,92 Furthermore, autophagy—a crucial self-protective mechanism inherent to cells—exhibits complex changes during ovarian aging. The autophagy-related marker LC3II shows dynamic fluctuations across different stages of ovarian aging. Research indicates that ovarian aging is accompanied by excessive autophagy activation mediated by the PINK1/Parkin pathway. This hyperactivated autophagy disrupts intracellular homeostasis, leading to granulosa cell dysfunction and subsequent cell death, thereby accelerating ovarian aging. The traditional Chinese medicine formula Heshi Yangchao Formula (HSYCF, Héshì Yǎngcháo Fāng, a kidney-tonifying herbal compound for the intervention of ovarian aging) suppresses excessive autophagy in ovarian tissue, reduces LC3II expression levels, decreases autophagosome formation, and promotes the restoration and reconstruction of ovarian function, offering novel therapeutic insights and approaches for ovarian aging.89 In summary, assessing hormone levels, oxidative stress markers (SOD, MDA, etc)., inflammatory factors (IL-6, TNF-α, etc)., and autophagy-related markers in vivo provides an objective and accurate method to evaluate the regulatory effects of TCM on ovarian cells. The above detection indicators have different focuses on reflecting ovarian aging in different dimensions, and their clinical value and limitations need to be systematically balanced. AMH is currently considered the most reliable single biochemical indicator due to its stability that does not fluctuate with the menstrual cycle and its high correlation with the number of antral follicles; FSH is significantly affected by the menstrual cycle, and INHB shows abnormal decline earlier than FSH, showing changes in the early stages of ovarian reserve decline. However, due to its short half-life and being affected by follicular development stages, its clinical application is not as widespread as AMH. Inflammatory factors (TNF-α, IL-6) and oxidative stress markers (SOD, MDA) reflect the process of functional damage rather than reserve stock, and cannot be used independently for diagnosis, but can be used as indicators for evaluating the efficacy of traditional Chinese medicine. The results from these biomarker assays provide crucial experimental evidence and theoretical support for elucidating the mechanisms underlying traditional Chinese medicine’s anti-ovarian aging effects, thereby aiding in the exploration of its potential applications in preventing and treating ovarian aging. Ultrasound Imaging Assessment Dynamic changes in ovarian reserve function can be systematically evaluated using multimodal ultrasound imaging techniques, with the core assessment system comprising the antral follicle count (AFC) and ovarian volume (OV) measured via transvaginal three-dimensional ultrasound.93 Clinical studies indicate that follicle numbers decline markedly with age, while ovarian volume reduction is less pronounced than follicular depletion. This suggests AFC more accurately reflects ovarian reserve changes and exhibits a strong positive correlation with AMH levels.94 In a specific retrospective analysis of 492 reproductive-age women, AFC and OV demonstrated correlation coefficients with AMH of 0.844 and 0.759, respectively, indicating that 3D ultrasound can accurately predict AMH levels. Three dimensional AFC and ovarian volume are core non-invasive imaging techniques with high correlation with serum AMH. However, ultrasound may have subjective interpretation bias by the operator. Therefore, the combined evaluation of follicle count and anti-Mullerian hormone can more comprehensively reflect ovarian reserve function and guide clinical treatment strategies.95 Additionally, hemodynamic indicators such as peak systolic velocity (PSV) and resistance index (RI), though showing weaker correlations with AMH, remain valuable supplementary assessment tools.96 Molecular Biology Analysis In the field of ovarian aging related research, the application of molecular biology techniques is showing an increasingly widespread trend. In the physiological and pathological process of ovarian aging, the intervention of high-throughput technologies such as transcriptomics, metabolomics, and proteomics has expanded the molecular mechanism research of ovarian aging from the “single gene single pathway” model to the “networked dynamic” system level, accurately targeting multiple key pathological links. Heshi Yangchao Formula (HSYCF) promotes follicular development in aged mice and improves age-related mitochondrial dysfunction, apoptosis, and DNA damage repair defects. Transcriptomic and metabolomic analyses confirm that the glutathione metabolic pathway is the key mechanism through which HSYCF counteracts ovarian aging.97 In acupuncture treatment experiments on rats with premature ovarian insufficiency models, Wei conducted in-depth analysis using metabolomics techniques.16 Results revealed that the taurine-pyridoxine metabolic pathway serves as a pivotal antioxidant axis in delaying ovarian aging. Furthermore, proteomic analysis revealed acupuncture-mediated reversal of 115 ovarian proteins, particularly PPAR signaling components (FABP5, ADIPOQ, and PLIN1). This indicates acupuncture precisely coordinates lipid metabolic reprogramming within ovarian tissue, providing a novel systems biology framework for understanding traditional drug interventions in reproductive aging. Moreover, diminished ovarian reserve is closely linked to genetic factors. Among these, variations at specific genetic loci significantly impact ovarian function. For instance, the rs2293275 variant in the LHCGR gene exhibits high correlation with premature ovarian insufficiency.98 The application of these molecular technologies not only provides a mechanistic basis for traditional Chinese medicine treatments but also offers scientific support for developing precise diagnostic and intervention strategies. Functional Dynamic Testing In ovarian function assessment, functional testing focuses on the actual presentation of ovarian physiological function, with particular emphasis on in vitro fertilization (IVF) responsiveness and oocyte quality evaluation. The ovarian response to ovulation-inducing medications and the quantity and quality of retrieved oocytes serve as critical indicators for evaluating ovarian function. These indicators provide a direct and precise reflection of ovarian functional status within the reproductive physiological process, offering crucial evidence for subsequent treatment strategy formulation and efficacy assessment. Among infertile women undergoing IVF, diminished ovarian reserve markers—including antral follicle count and anti-Müllerian hormone—are primary indicators of reduced pregnancy potential. Furthermore, integrating functional testing with molecular biomarker analysis provides robust supplementary support for prognosis assessment and recurrence risk evaluation in ovarian diseases. Molecular markers such as miR-21, HE4, and CA125 play crucial roles in monitoring ovarian conditions. Research has confirmed that these molecular markers exhibit high sensitivity and specificity in ovarian cancer surveillance. Precise detection and analysis of these markers enable timely identification of potential ovarian disease risks and prediction of disease progression, thereby effectively enhancing treatment outcomes and patient quality of life99 (Figure 2A). In summary, modern ovarian function assessment encompasses multiple dimensions including biochemical indicators, imaging, and molecular biological analysis. A horizontal comparison reveals of the ovarian aging detection system mentioned above. Biochemical hormone detection is easy to operate, has low detection costs, and is suitable for initial screening scenarios in large-scale populations; Ultrasonic testing has the advantages of complete non invasiveness and intuitive results, and can serve as a key evidence supplement for morphological dimensions. Multi omics molecular techniques have significant advantages in analyzing underlying mechanisms, but there are still limitations in clinical translation; The scope of clinical applicability of functional dynamic testing is relatively narrow. These complementary and synergistic detection techniques collectively form a comprehensive, systematic, and integrated evaluation system for ovarian function, enabling precise reflection of ovarian physiological status and functional changes from multiple perspectives. Traditional Chinese medicine demonstrates potential value in delaying ovarian aging by improving these assessment indicators through hormone regulation, ovarian stem cell protection, and antioxidant stress mitigation. In the future, by combining high-throughput molecular technology and advanced imaging techniques, a layered and graded comprehensive evaluation system for ovarian aging will be constructed, providing a more solid foundation for accurate diagnosis and personalized treatment of ovarian aging. Development of Animal Models for Ovarian Aging and Experimental Methods Selection of Model Animals Different species exhibit variations in ovarian structure, physiological functions, and aging characteristics, necessitating selection based on research objectives. Mice are the most commonly used model (eg, C57BL/6 strain), featuring a well-defined genetic background. Inbred mouse lines exhibit high genetic homogeneity, minimizing experimental errors caused by individual genetic differences during studies. Additionally, mice exhibit a short reproductive cycle, completing one cycle approximately every 3–4 weeks, and produce multiple offspring per litter, enabling rapid acquisition of large numbers of experimental subjects within a short timeframe. Furthermore, gene editing tools (such as CRISPR-Cas9 and transgenic technology) are well-established in mice, facilitating the construction of genetically modified ovarian aging models for in-depth investigation of molecular mechanisms. Rats, being larger in size, offer advantages for ovarian-related surgical procedures (eg, partial ovariectomy, follicle transplantation). Their anatomy provides more favorable conditions for surgical manipulation, enhancing procedural success rates and precision. Furthermore, sample collection methods like tail vein blood sampling and cardiac puncture are more readily implemented. This makes rats suitable for studies requiring repeated dynamic monitoring of endocrine indicators (eg, serum E2 and FSH changes). They are widely used in evaluating the endocrine disruption mechanisms of ovarian aging and the efficacy of drug interventions.100 Among other models, guinea pigs serve as a favorable system for ovarian aging research due to certain physiological similarities with humans, such as exhibiting a rudimentary menstrual cycle pattern.101 Non-human primates demonstrate high consistency with humans in ovarian anatomy, follicular development processes, and hormonal regulatory patterns, making them the most ideal model for simulating human ovarian aging.102 Particularly suited for preclinical studies on follicular dynamics, mechanisms of menopause-related diseases, and reproductive medical interventions (eg, stem cell therapy, in vitro follicular culture). However, their application is relatively limited due to extended reproductive cycles, high maintenance costs, and stringent ethical constraints. In order to more intuitively demonstrate the differences between each model, we have summarized the characteristics of the above models in Table 1. Table 1Comparison of Selection Criteria and Characteristics of Different Species Models in Ovarian Aging ResearchSpeciesAdvantages/Applicable ScenariosLimitationsRecommended Research ObjectivesMouseClear genetic background, highly homogeneous genes in inbred lines;Short breeding cycle (3–4 weeks), resulting in more offspring; Mature application of gene editing tools (CRISPR-Cas9, etc.).Small size, relatively difficult surgical operation;Limited sample collection volume.Molecular mechanism exploration;Construction of specific gene modification models; Large scale drug screening.RatLarge in size, convenient for surgical operations (such as partial resection or transplantation);Easy to dynamically collect blood multiple times to monitor endocrine indicators.Gene editing resources are relatively limited compared to mice;Feeding is slightly higher than in mice.Research on the mechanism of endocrine disorders;Pharmacokinetic studies requiring frequent blood collection; Evaluation of the Effectiveness of Complex Surgical Interventions.Guinea pigHaving a prototype of a menstrual cycle similar to that of humans;Physiological characteristics have certain similarities with humans.Relatively lacking genetic background and tools;High requirements for feeding management.Simulation of human menstrual cycle related research; Preliminary preclinical validation.Non-human primatesThe anatomical structure, follicular development, and hormone regulation are highly consistent with those of humans;The most ideal model for simulating human ovarian aging.Long breeding cycle and extremely high feeding cost;Strict ethical restrictions and restricted sources.Follicle dynamics research;Mechanisms of menopausal diseases; Preclinical translational studies such as stem cell/in vitro culture. Comparison of Selection Criteria and Characteristics of Different Species Models in Ovarian Aging Research Clear genetic background, highly homogeneous genes in inbred lines; Clear genetic background, highly homogeneous genes in inbred lines; Short breeding cycle (3–4 weeks), resulting in more offspring; Short breeding cycle (3–4 weeks), resulting in more offspring; Mature application of gene editing tools (CRISPR-Cas9, etc.). Mature application of gene editing tools (CRISPR-Cas9, etc.). Small size, relatively difficult surgical operation; Small size, relatively difficult surgical operation; Limited sample collection volume. Limited sample collection volume. Molecular mechanism exploration; Molecular mechanism exploration; Construction of specific gene modification models; Construction of specific gene modification models; Large scale drug screening. Large scale drug screening. Large in size, convenient for surgical operations (such as partial resection or transplantation); Large in size, convenient for surgical operations (such as partial resection or transplantation); Easy to dynamically collect blood multiple times to monitor endocrine indicators. Easy to dynamically collect blood multiple times to monitor endocrine indicators. Gene editing resources are relatively limited compared to mice; Gene editing resources are relatively limited compared to mice; Feeding is slightly higher than in mice. Feeding is slightly higher than in mice. Research on the mechanism of endocrine disorders; Research on the mechanism of endocrine disorders; Pharmacokinetic studies requiring frequent blood collection; Pharmacokinetic studies requiring frequent blood collection; Evaluation of the Effectiveness of Complex Surgical Interventions. Evaluation of the Effectiveness of Complex Surgical Interventions. Having a prototype of a menstrual cycle similar to that of humans; Having a prototype of a menstrual cycle similar to that of humans; Physiological characteristics have certain similarities with humans. Physiological characteristics have certain similarities with humans. Relatively lacking genetic background and tools; Relatively lacking genetic background and tools; High requirements for feeding management. High requirements for feeding management. Simulation of human menstrual cycle related research; Simulation of human menstrual cycle related research; Preliminary preclinical validation. Preliminary preclinical validation. The anatomical structure, follicular development, and hormone regulation are highly consistent with those of humans; The anatomical structure, follicular development, and hormone regulation are highly consistent with those of humans; The most ideal model for simulating human ovarian aging. The most ideal model for simulating human ovarian aging. Long breeding cycle and extremely high feeding cost; Long breeding cycle and extremely high feeding cost; Strict ethical restrictions and restricted sources. Strict ethical restrictions and restricted sources. Follicle dynamics research; Follicle dynamics research; Mechanisms of menopausal diseases; Mechanisms of menopausal diseases; Preclinical translational studies such as stem cell/in vitro culture. Preclinical translational studies such as stem cell/in vitro culture. Comparing the four experimental species horizontally, it can be seen that different species have differences in simulating human ovarian aging. Mice have become the preferred choice for mechanism research and drug screening due to their short reproductive cycle, mature gene editing tools, and controllable cost. However, their ovarian structure is significantly different from that of humans, which may simplify certain microenvironmental regulatory mechanisms in mouse ovaries. Although rats are superior to mice in terms of surgical operability, they lack a clear estrous cycle during menopause, making it difficult to simulate the dramatic hormonal fluctuations of human perimenopause. Guinea pigs only have follicular cycles similar to humans, with a lack of reagents and gene editing tools, and narrow application scenarios; The clinical translational value of non-human primates is the highest, but due to high feeding costs and strict ethical review restrictions on experiments, it is only suitable for a few preclinical validations. Literature comparison shows that some kidney tonifying traditional Chinese medicines that are effective in naturally aging mice have not shown the same ovulation inducing effect in primates. This suggests that we need to be cautious when interpreting the results of rodent experiments. Researchers need to weigh the advantages and disadvantages of different species based on the core objectives of the experiment and should not blindly choose a single species. Common Types of Animal Models for Ovarian Aging In scientific research exploring the mechanisms of ovarian aging and evaluating the efficacy of traditional Chinese medicine treatments, animal models serve as critical research tools. They can accurately simulate the dynamic changes in ovarian function under various pathological conditions, enabling in-depth analysis of the pathophysiological mechanisms of ovarian aging and the exploration of effective intervention strategies. Currently, the primary animal model types widely applied in related research encompass natural aging models, drug-induced models, surgical models, and genetically engineered models. Each model type possesses distinct characteristics and applicable scopes. The appropriate selection and application of corresponding animal models enable more scientific and accurate research into ovarian aging mechanisms and the therapeutic effects of traditional Chinese medicine (Figure 2B). Natural Aging Model The natural aging model faithfully replicates the series of ovarian functional changes observed in animals as they age. With increasing organismal age, ovarian reserve function gradually declines, manifested by a reduction in the number and quality of follicles within the ovaries. Hormonal levels also undergo significant alterations, such as abnormal fluctuations in the secretion of sex hormones like estrogen and progesterone. Concurrently, follicular development becomes disrupted, leading to arrested development and atresia. These characteristics closely mirror the physiological changes observed during natural ovarian aging in females. Consequently, this model exhibits high physiological relevance, providing a highly realistic reference framework for investigating the mechanisms of female ovarian aging. The natural aging model possesses numerous significant advantages, most notably its ability to faithfully reflect the true physiological process of ovarian aging. The research outcomes obtained from this model exhibit high credibility and clinical reference value. However, the model also has some limitations that cannot be ignored. Because it relies on the natural growth and aging processes of animals, the experimental cycle is relatively long, requiring considerable time to wait for the animals to reach the corresponding aging stage. Furthermore, variations in genetic background, living environments, and health status among individual animals may lead to substantial inter-individual differences in the rate and extent of ovarian aging. This increases experimental variability, potentially affecting the reproducibility and stability of the results. Drug-Induced Models In establishing research models related to ovarian function decline, drug-induced models utilize specific chemotherapeutic agents such as cyclophosphamide and 4-vinylcyclohexene diepoxide to induce ovarian damage, thereby creating experimental models of ovarian dysfunction.103–105 The most representative model is the premature ovarian insufficiency induced by cyclophosphamide combined with busulfan. A single intraperitoneal injection of 120 mg/kg cyclophosphamide and 30 mg/kg busulfan causes damage to mouse ovarian tissue. Under this drug action, the ovaries sustain injury, leading to a reduction in follicle number and deterioration in follicle quality. Concurrently, serum FSH levels significantly increase, while E2 and SOD levels markedly decrease.106 These physiological changes precisely mimic the pathological state of rapid ovarian decline observed in clinical chemotherapy patients, providing a reliable experimental basis for investigating chemotherapy’s impact on ovarian function. Drug-induced models offer several distinct advantages. Compared to other model construction methods, this approach rapidly induces ovarian dysfunction in experimental animals, significantly shortening research cycles and enhancing efficiency. The drug-induced model is highly suitable for evaluating the protective effects of traditional Chinese medicine and other interventions against chemotherapy-induced ovarian damage. Through this model, researchers can systematically observe and analyze the impact of different interventions on damaged ovarian tissue structure, endocrine indicators, and antioxidant capacity, thereby providing scientific basis for developing effective ovarian protective drugs and therapeutic strategies. Surgical Models Surgical models induce ovarian dysfunction directly through complete or partial removal of the ovaries. These models are highly suitable for in-depth investigation of the physiological changes occurring in the body following ovarian tissue loss, demonstrating significant application value particularly in studying the pathogenesis and therapeutic strategies for diseases such as ovarian cancer. Following partial or complete ovarian removal, the body initiates a series of responses—including hormonal secretion adjustments and organ function adaptations—to maintain internal homeostasis. Surgical models enable precise observation and analysis of these adaptive processes, providing crucial insights into the ovaries’ vital role in maintaining physiological equilibrium. Conversely, surgical models are frequently employed to evaluate the efficacy of replacement therapies for ovarian insufficiency. For instance, when studying the effects of hormone replacement therapy or tissue transplantation on restoring ovarian function, these models provide a standardized experimental platform. By comparing physiological indicators and behavioral patterns in experimental animals before and after treatment, they enable objective assessments of the safety and efficacy of replacement therapies.107,108 Surgical models possess significant advantages: the pathological changes induced by surgery are clear and well-defined, and ovarian dysfunction directly leads to observable alterations in physiological indicators, such as fluctuations in hormone levels and loss of reproductive function. However, surgical models also have limitations. Since the surgery directly removes ovarian tissue, the model cannot reflect the intrinsic aging process of the ovaries. Ovarian aging is a complex physiological process involving multiple aspects, including gradual follicular depletion, altered hormone secretion, and cellular functional decline. These changes cannot be reflected in surgical models. Therefore, surgical models are primarily applied to studies on ovarian function deficiency states. To comprehensively understand the mechanisms of ovarian aging and develop integrated therapeutic approaches targeting ovarian aging, combined research with other model types is necessary. Genetically Engineered Models Genetically engineered models can precisely regulate genes associated with aging through techniques such as gene knockout, knock-in, or conditional expression, thereby simulating the molecular characteristics of human aging. By precisely deleting or inserting specific genes via gene editing technology, genetically modified models related to ovarian aging are constructed. Foxo transcription factors are involved in multiple biological processes, including metabolism, cellular stress responses, and aging. Foxo3a knockout mice exhibit premature activation of primordial follicles in the ovaries, accelerating follicular depletion and presenting a POI-like phenotype.109 Cytoskeleton Associated Protein 5 (CKAP5) has been identified as a key hub gene associated with ovarian aging. Heterozygous CKAP5 knockout mice demonstrate reduced primordial follicle pools and accelerated follicular atresia, exhibiting a POI-like phenotype.110 Additionally, introducing overexpression vectors for specific aging-related genes into animal genomes induces ovarian aging through tissue-specific or systemic overexpression. Common target genes include those associated with the senescence-associated secretory phenotype and telomerase reverse transcriptase mutants.111 For example, in transgenic mice overexpressing bGH specifically in the ovaries, the primordial follicle reserve in the ovaries of these model mice was significantly reduced. Concurrently, the expression level of the transcription factor Foxo3a in oocytes was markedly decreased. Its downregulation accelerated follicle depletion, propelling ovarian tissue into a state of aging. This provides important experimental evidence for further exploring the molecular regulatory network of ovarian aging.112 In summary, the four primary animal models commonly used in ovarian aging research each possess distinct research focuses. The natural aging model focuses on the realistic simulation of the physiological aging process, which can accurately present a series of changes that occur in the ovaries with age, reflect the process of physiological kidney essence deficiency. It is most in line with the traditional Chinese medicine “kidney deficiency syndrome”. It can provide an ideal paradigm for studying the intrinsic laws of kidney tonifying and essence filling prescriptions. The drug-induced model highlights simulation of pathological damage, using specific drugs to rapidly induce ovarian injury resembling clinical pathological states, enabling in-depth exploration of mechanisms and pathophysiological responses to external factors causing ovarian damage. The surgical model mainly focuses on the state of ovarian dysfunction, simulating the physiological and pathological changes caused by dysfunction through resection surgery, which is equivalent to the end-stage state of “renal essence depletion”. It is suitable for research on alternative therapies, but not for the study of the dynamic evolution process of the pathogenesis of “kidney deficiency”. Genetic engineering modeling techniques construct aging models with clearly defined molecular phenotypes by precisely regulating aging-related genes. Combined with technologies like organoids and single-cell sequencing, they create high-resolution aging maps, offering new approaches to delaying ovarian aging. By comparing the applicability boundaries and inherent limitations of the four types of models horizontally, it can be seen that some existing studies have problems with model selection not matching clinical conditions and model selection being singular. For example, using acute injury models to screen drugs for the treatment of “ovarian reserve dysfunction” may lead to overestimation of the repair effect of drugs. It is recommended to adopt a multi model cross validation scheme for future mechanism research, combining two or more models to conduct experiments simultaneously, offsetting experimental bias caused by a single modeling system, and improving the reliability of research conclusions and clinical translational reference value. Furthermore, integrating in vitro cellular experiments with in vivo studies precisely identifies the molecular mechanisms and specific signaling pathway targets involved in TCM treatment of ovarian aging. This approach comprehensively evaluates TCM efficacy at the macro level while elucidating its molecular mechanisms at the micro level, providing more comprehensive, in-depth, and reliable evidence for TCM applications in combating ovarian aging. In order to more intuitively demonstrate the differences between each model, we have summarized the characteristics of the above models in Table 2. Table 2Comparison of Advantages, Disadvantages, and Application Scenarios of Four Commonly Used Ovarian Aging Animal ModelsModel TypeModeling Principles/MethodsAdvantageLimitationApplicable Research ScenariosNatural Aging ModelDependent on natural animal growth, ovarian function declines with age.Highly realistic reflection of physiological aging process; The results have high credibility and significant clinical reference value.Long experimental cycle and high cost; Large individual differences and high variability in results.Suitable for studying the natural laws of ovarian physiological aging, long-term drug intervention effects, and lifespan research.Drug induced modelUsing drugs such as cyclophosphamide, buxostat, or VCD to damage the ovaries.Short molding time and high efficiency;Can accurately simulate chemotherapy injury or specific pathological conditions.Only simulating pathological damage, not natural aging;Drug toxicity may affect other organs.Suitable for studying the mechanism of premature ovarian failure (POI), protecting against reproductive toxicity of chemotherapy drugs, and evaluating the emergency efficacy of traditional Chinese medicine.Surgical modelOvary resection or partial resection.Clear and definite pathological changes; High standardization level, suitable for alternative therapy research.Unable to reflect the intrinsic aging process of the ovaries;Lack of dynamic changes in follicular depletion, only simulating functional loss.Suitable for the study of compensatory mechanisms in postmenopausal syndrome (such as osteoporosis), hormone replacement therapy (HRT), and ovarian deficiency.Genetic engineering modelGene knockout/knock in/overexpression (such as FOXO3a, CKAP5, bGH, etc.).Precise regulation of specific molecular targets;Can simulate premature aging caused by specific gene mutations.Difficulty in construction and high cost;A single gene change may not fully represent the complex natural aging network.Suitable for validation of specific signaling pathways (such as PI3K/Akt, mTOR, etc.), functional analysis of key aging genes, and target screening. Comparison of Advantages, Disadvantages, and Application Scenarios of Four Commonly Used Ovarian Aging Animal Models Highly realistic reflection of physiological aging process; Highly realistic reflection of physiological aging process; The results have high credibility and significant clinical reference value. The results have high credibility and significant clinical reference value. Long experimental cycle and high cost; Long experimental cycle and high cost; Large individual differences and high variability in results. Large individual differences and high variability in results. Short molding time and high efficiency; Short molding time and high efficiency; Can accurately simulate chemotherapy injury or specific pathological conditions. Can accurately simulate chemotherapy injury or specific pathological conditions. Only simulating pathological damage, not natural aging; Only simulating pathological damage, not natural aging; Drug toxicity may affect other organs. Drug toxicity may affect other organs. Clear and definite pathological changes; Clear and definite pathological changes; High standardization level, suitable for alternative therapy research. High standardization level, suitable for alternative therapy research. Unable to reflect the intrinsic aging process of the ovaries; Unable to reflect the intrinsic aging process of the ovaries; Lack of dynamic changes in follicular depletion, only simulating functional loss. Lack of dynamic changes in follicular depletion, only simulating functional loss. Precise regulation of specific molecular targets; Precise regulation of specific molecular targets; Can simulate premature aging caused by specific gene mutations. Can simulate premature aging caused by specific gene mutations. Difficulty in construction and high cost; Difficulty in construction and high cost; A single gene change may not fully represent the complex natural aging network. A single gene change may not fully represent the complex natural aging network. Phenotypic Assessment and Experimental Methods for Ovarian Aging Reproductive Function and Estrous Cycle Evaluation In studies investigating traditional Chinese medicine treatments for ovarian aging, precise quantitative assessment of reproductive capacity serves as the most direct indicator of ovarian function status. For estrous cycle monitoring, daily vaginal smear techniques can be employed to collect exfoliated vaginal epithelial cell samples from mice. After air-drying, these samples undergo Papanicolaou staining and microscopic examination to determine estrous phase. Based on the relative proportions of keratinized epithelial cells, nucleated epithelial cells, and polymorphonuclear leukocytes, researchers can distinguish among proestrus (predominantly nucleated epithelial cells with few keratinized cells), estrus (massive accumulation of non-nucleated keratinized epithelial cells), metestrus (mixed keratinized cells and leukocytes), and anestrus (highest leukocyte proportion with few epithelial cells).113 This enables analysis of cyclical regularity, duration, and phase proportion shifts during ovarian aging.73 When ovarian function begins to decline, behavioral changes often manifest as estrous cycle irregularities and significantly prolonged diestrus periods, serving as early behavioral markers of ovarian dysfunction. Analysis of fertility indicators is also crucial for assessing ovarian function. Female mice are cohabited with male mice of known normal fertility at a specific ratio, and mating success is confirmed by observing the appearance of vaginal plugs. Throughout this process, key reproductive parameters—including mating rate, pregnancy rate, average litter size, inter-litter interval, and cumulative litter number—are continuously and meticulously recorded. A significant decline in these indicators indirectly reflects a comprehensive decline in ovarian ovulatory function, oocyte quality, and uterine receptivity, providing crucial reference for evaluating ovarian function and the efficacy of Chinese herbal medicine treatment.114 Endocrine Level Testing The endocrine function of the ovaries plays a central role in maintaining reproductive system homeostasis, while endocrine dysfunction is a key characteristic of ovarian aging. Quantitative hormone analysis is the core step in endocrine level testing. Key hormone levels are measured using enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassay (CLIA), each hormone carrying specific clinical significance: Elevated follicle-stimulating hormone levels are a major indicator of diminished ovarian reserve; fluctuations in estradiol levels reflect follicular development and ovulatory function; Anti-Müllerian hormone directly assesses the reserve of primordial follicles in the ovaries, with decreased levels closely associated with ovarian aging; Inhibin B, secreted by preantral and small antral follicles, serves as an indicator of follicular development capacity. Precise detection of these hormone levels enables a comprehensive and in-depth understanding of ovarian endocrine function, providing crucial data support for research into traditional Chinese medicine treatments for ovarian aging. Ovarian Morphology and Histological Analysis Histological analysis provides the most direct morphological evidence for ovarian reserve and structural integrity. Ovaries are collected and weighed, with the ovarian index (ovarian weight/body weight × 100%) calculated as an intuitive indicator for assessing ovarian development and atrophy. Hematoxylin-Eosin (HE) staining, as a fundamental and classical method, clearly reveals the overall tissue architecture of the ovary. It allows observation of the distribution and arrangement of follicles at various stages within ovarian tissue. Blind counting of follicles at different stages is performed: primordial follicles (oocytes surrounded by poorly differentiated squamous granulosa cells), primary follicles (oocyte surrounded by a single layer of cuboidal granulosa cells), secondary follicles (oocyte surrounded by multiple layers of granulosa cells, without a follicular cavity), antral follicles (with follicular cavity formation), and atretic follicles (with deformed or absent oocytes and loosely detached granulosa cells). The number and proportion of each follicular type are quantified to assess ovarian follicular reserve and developmental status, enabling preliminary evaluation of basic ovarian structure integrity.115–117 Immunohistochemistry (IHC) provides deeper insights by specifically detecting the localization and expression intensity of target proteins within ovarian tissue. By labeling proteins associated with follicular development and cellular function, these techniques precisely elucidate the mechanisms of key molecules during follicular maturation, enabling more detailed assessment of follicular development. The terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) assay specifically detects apoptosis levels by labeling DNA fragmentation characteristic of apoptotic cells, accurately identifying and quantifying apoptotic cells within ovarian tissue. The combined application of these techniques enables comprehensive and in-depth observation of ovarian structural characteristics, follicular development progression, and specific levels of cellular apoptosis. This provides detailed and reliable morphological evidence for evaluating the efficacy and studying the mechanisms of traditional Chinese medicine in treating ovarian aging. Cellular and Molecular Biology Techniques In-depth investigation of the underlying mechanisms of ovarian aging at the molecular level is a current research priority. Key technical approaches include gene and protein expression analysis, oxidative stress level assessment, telomere length detection, and high-throughput sequencing technologies. Real-time quantitative PCR technology enables precise quantification of mRNA expression levels for genes associated with aging, apoptosis, autophagy, and oxidative stress by extracting total RNA from ovarian tissue and performing reverse transcription. Western blotting, meanwhile, involves extracting total protein from ovarian tissue to detect expression levels of specific target proteins and their post-translational modifications such as phosphorylation, thereby validating related mechanisms at the protein level. Telomere shortening, a key hallmark of cellular aging, can be relatively quantified via qPCR or precisely measured using Southern Blot analysis of telomeric restriction fragment lengths for greater accuracy.118 Furthermore, the application of high-throughput sequencing technologies has significantly expanded the depth and breadth of research. For instance, transcriptome sequencing enables comprehensive analysis of young and aged ovarian tissues. Combined with bioinformatics methods, it identifies differentially expressed genes and performs signaling pathway enrichment analysis, thereby systematically revealing the molecular regulatory networks underlying ovarian aging. While single-cell RNA sequencing effectively overcomes tissue heterogeneity limitations. At single-cell resolution, it deciphers the specific gene expression profiles of different ovarian cell types—including oocytes, granulosa cells, theca cells, and stromal cells—during the aging process, providing an unprecedented research perspective for precisely elucidating the aging characteristics of various cell types and their interaction mechanisms. Furthermore, experimental designs for traditional Chinese medicine interventions targeting ovarian aging must scientifically determine drug dosages, administration routes, and therapeutic windows to ensure study reliability and clinical translational value. In summary, adopting multidimensional, systematic approaches to assess ovarian aging phenotypes enables rigorous scientific elucidation of traditional Chinese medicine mechanisms regulating ovarian function, laying a robust foundation for clinical applications and novel drug development. Research on the Mechanism of Traditional Chinese Medicine in Delaying Ovarian Aging Based on the pathological mechanism of ovarian aging described earlier, the traditional Chinese medicine system has shown significant application prospects in delaying ovarian aging lesions due to its unique advantages of multi-component synergistic effects, multi-target combined intervention, and overall regulation. (Figure 3). Regulatory mechanism of ovarian aging-related signaling pathways. This figure illustrates the key signaling pathways regulating ovarian function, including the PI3K/Akt pathway, which regulates stem cell viability, follicular development, and cell apoptosis by affecting molecules such as P21, mTOR, and Bax; the NF-κB pathway, which mediates inflammatory responses and affects ovarian reserve function; the MAPK pathway (ERK1/2, p38, JNK), which is involved in the regulation of follicular development and cell apoptosis; the Nrf2/HO-1 pathway, which responds to ROS and regulates oxidative stress and redox balance; and the AMPK/mTOR pathway, which regulates autophagy to reduce cell damage. The black solid arrows in the figure represent the “promoting” effect, the red flat headed lines represent the “inhibiting” effect, and the dashed arrows represent indirect, downstream, or comprehensive regulatory results (ie, not direct intermolecular interactions, but functional causal connections or cascade reactions). These pathways work together to maintain ovarian cell survival, redox balance, and functional homeostasis. Tonifying Kidney and Filling Essence Method-Targeting the PI3K/Akt/mTOR Pathway to Promote Follicle Development and Stem Cell Activation According to traditional Chinese medicine theory, the kidney stores essence, controls reproduction, and is the foundation of innate nature. The fundamental reason for the decline in ovarian reserve function and follicular depletion is the deficiency of kidney essence. Traditional Chinese medicine supplements the material basis and restores and maintains the functional balance of the reproductive axis of “kidney Tian Gui Chong Ren twin palace” through the effects of tonifying the kidneys, harmonizing qi and blood, etc. The PI3K/Akt signaling pathway is an important molecular mechanism that regulates follicular activation, cell proliferation, and ovarian reserve function. This pathway can participate in ovarian development and functional maintenance by mediating cell growth and metabolism. By activating this signaling pathway, the intrinsic vitality of ovarian stem cells can be effectively enhanced, promoting their more active proliferation and differentiation.119 This process not only promotes the formation of new follicles, providing a foundation for the recovery of ovarian reserve function, but also stimulates the generation of blood vessels inside the ovary. The newly formed vascular network can deliver more abundant nutrients and oxygen to damaged ovarian tissue, thereby accelerating the repair process of damaged ovarian tissue and ultimately achieving significant improvement in ovarian reserve function. It is worth noting that Akt not only directly phosphorylates Bax to inhibit apoptosis, but also acts as an upstream kinase to phosphorylate IKK complex, thereby activating the NF-κB pathway. This explains why some pro proliferative traditional Chinese medicines also have anti-inflammatory effects.120 In addition, Akt’s activation of mTOR also forms an antagonistic balance with the AMPK pathway in energy metabolism, jointly determining the synthesis and catabolic metabolic status of cells. Therefore, the activation of this pathway by the kidney tonifying and essence filling method is not an isolated event, but can generate a synergistic network effect of “promoting proliferation anti apoptosis anti-inflammatory angiogenesis” through node linkage. Various kidney tonifying and essence filling traditional Chinese medicines and formulas have been proven to improve ovarian function by activating the PI3K/Akt/mTOR pathway. Traditional Chinese medicines such as Astragali Radix and Epimedium can promote ovarian tissue repair and follicle growth and development by activating the PI3K/Akt/mTOR pathway, thereby enhancing ovarian reserve capacity.121 Medicinal and edible yam is commonly used to treat premature ovarian failure. Through experimental identification, it was found that the core components were determined to be erosive hormone B and sea breeze vine ketone. After treatment with yam in POI rats, hormone levels returned to normal levels and the number of blocked follicles decreased; And the active ingredients in yam can regulate the PI3K/AKT/P21 signaling pathway, increase the phosphorylation levels of PI3K and AKT proteins, inhibit the expression of P21 protein, thereby promoting the proliferation of oocyte stem cells, restoring stem cell activity, and delaying ovarian aging.122 In the traditional Chinese medicine formula Sijunzi Decoction, active ingredients such as ginsenoside Rg1 can promote the proliferation and survival of ovarian granulosa cells, inhibit their apoptosis, reduce follicular atresia, and improve ovarian reserve function by activating EGFR and the PI3K/Akt signaling pathway.123 In addition, ginsenoside Rg1 can maintain the balance of pro apoptotic and anti apoptotic proteins in the ovary by regulating apoptosis related pathways such as Bax/cytc/caspase-3, thereby enhancing the ovarian anti-aging ability.124 Bazi Bushen Formula (BZBSF) is an innovative patented traditional Chinese medicine that can be used to alleviate ovarian aging caused by insufficient kidney essence. Experimental results have shown that BZBSF treatment can effectively restore hormone levels and activate the NF2-YAP pathway, effectively reduce the degree of cell apoptosis, and achieve the goal of delaying the process of premature ovarian failure.125 The method of tonifying kidney and replenishing essence also has a positive regulatory effect on ovarian stem cells. At the cellular level, the method of nourishing the kidney and replenishing essence plays a key regulatory role in the proliferation and maintenance of ovarian stem cells. Proanthocyanins (PACs) can upregulate the mRNA and protein expression of stem cell (FGSCs) specific markers MVH and OCT4, activate the Sirt1 signaling pathway, downregulate p53/p21, significantly promote FGSCs proliferation, and protect against pathological ovarian aging.126 The regulatory effect of the classic kidney tonifying formula Zuogui Pill (ZGP) is more systematic: in the cyclophosphamide induced ovarian aging model, ZGP increases SOD and GSH-Px activity, reduces MDA and ROS accumulation, restores the body’s antioxidant capacity, and creates a favorable microenvironment for stem cell survival. On the other hand, ZGP directly regulates the cell cycle of ovarian stem cells by upregulating the expression of Cyclin D1 and Cyclin E1, reasonably regulating the expression of CDKN1A, increasing the levels of stem cell markers such as MVH, Oct4, BrdU, and upregulating the expression of Notch1 and Nrf2 in aging ovarian tissue and OSCs. Through these effects, ZGP ultimately restores the stem cell characteristics of OSCs, effectively preventing chemotherapy induced ovarian aging.97,127,128 In summary, the PI3K/Akt pathway, as one of the core signaling pathways regulating ovarian aging through traditional Chinese medicine, regulates cell proliferation, apoptosis, and antioxidant mechanisms through the “tonifying kidney and replenishing essence” method, affecting follicle activation and ovarian reserve function. These effects work together to effectively delay the aging process of the ovaries and help optimize and improve reproductive function. Warming the Kidney and Promoting Yang-Targeting AMPK/mTOR and Mitochondrial Function to Improve Energy Metabolism Kidney yang is the foundation of all yang, mainly warming and transforming. The pathological characteristics of the uterus deficiency cold syndrome and the overall decrease in basal metabolic rate, which are often accompanied by ovarian aging, are highly consistent with the core pathogenesis of “kidney yang deficiency and decline” in traditional Chinese medicine theory. The core target of the warming kidney and assisting yang therapy is to target and enhance the local energy supply level and cellular metabolic activity of the ovary. The AMPK/mTOR pathway and mitochondrial function are the core hubs of cellular energy metabolism, playing an important role in maintaining cellular homeostasis. Activated AMPK can exert inhibitory effects on the mTOR signaling pathway through a series of complex signaling mechanisms. This inhibitory effect further triggers the enhancement of cellular autophagy, prompting cells to actively clear harmful components such as damaged organelles and misfolded proteins, reducing the accumulation of metabolic waste within the cell, lowering the degree of cellular damage, and ultimately achieving the goal of delaying cellular aging.88 Research in traditional Chinese medicine has found that Chinese herbal formulas or individual components can finely regulate the AMPK/mTOR signaling pathway, cleverly coordinating the dynamic balance between cell autophagy and apoptosis. On the one hand, by enhancing cellular autophagy activity, timely clearing oxidative stress products and damaged organelles within cells, the degree of oxidative stress damage to cells can be reduced. On the other hand, moderate inhibition of cell apoptosis process reduces excessive loss of ovarian cells, thereby achieving protection and repair of ovarian function.129 The Bushen Huatan Huoxue Formula (Bǔshèn Huàtán Huóxuè Fāng, a compound formula tonifying kidney, resolving phlegm and activating blood circulation to ameliorate ovarian aging) activates the AMPK signaling pathway, improves metabolic homeostasis, promotes the transformation of white adipose tissue to brown adipose tissue (ie white adipose tissue browning), alleviates the pathological state of polycystic ovary syndrome, and demonstrates the key role of the AMPK/mTOR pathway in regulating ovarian function and metabolic balance.130 In addition, mitochondrial dysfunction can also cause iron death in ovarian cells. Iron induced cell death is a novel cell death mode driven by iron dependent lipid peroxidation reactions, which is closely related to the aging process of the ovary. The Wenyang type traditional Chinese medicine Erzhi Tiangui Decoction has been proven to maintain PINK1/Parkin mediated mitochondrial homeostasis, reduce lipid peroxidation caused by ROS accumulation, effectively inhibit iron death, and thus achieve the goal of delaying ovarian aging process.131 The AMPK/mTOR signaling pathway and mitochondrial function serve as key hubs connecting energy metabolism, autophagy, and cell survival, playing a central regulatory role in the occurrence and development of ovarian aging. Traditional Chinese medicine uses the “warming yang” treatment method to repair mitochondrial structure and physiological function, thereby delaying ovarian aging. From the perspective of regulating network interactions, AMPK and PI3K/Akt form a fine energy metabolism regulatory network on mTOR nodes. When the ovary is in a state of nutrient deficiency or stress, activated AMPK inhibits mTOR and initiates protective autophagy; PI3K/Akt can activate mTOR under the stimulation of reproductive hormones, promoting cellular synthesis processes. Various traditional Chinese medicine formulas can achieve bidirectional regulation of this pathway, avoiding cell death caused by excessive autophagy and blocking premature follicular depletion caused by sustained activation of mTOR, opening up new avenues for the prevention and treatment of ovarian related diseases. Promoting Blood Circulation and Removing Stasis Method-Targeting NF-κB/MAPK Pathway to Inhibit Inflammation and Fibrosis “Long term illness entering the meridians and forming blood stasis” is a classic pathogenic theory in traditional Chinese medicine. Kidney deficiency leads to weak circulation of qi and blood, blood stasis obstructs the Chong and Ren meridians, resulting in ovarian microcirculation disorders and local chronic inflammation. The intervention principles of promoting blood circulation and removing blood stasis aim to optimize local blood flow perfusion efficiency and eliminate accumulated inflammatory pathological metabolites in the body. The pathological state of ovarian aging is often accompanied by the occurrence of chronic low-grade inflammation. Inflammatory factors can damage the function of granulosa cells, induce their apoptosis, and lead to follicular development arrest or atresia. NF-κB is a widely present transcription factor protein family. The NF-κB signaling pathway serves as the core regulatory hub of inflammatory response and plays a crucial role in the inflammatory microenvironment during ovarian aging.132 Activation of the NF-κB pathway can disrupt the ovarian microenvironment, further exacerbating the degree of ovarian tissue damage. MAPK is an important transmitter of signals from the cell surface to the interior of the nucleus. The MAPK signaling pathway is composed of MAPKKK (MAPK kinase), MAPKK (MAPK kinase), and MAPK. Tertiary kinases are sequentially activated and participate in internal and external reactions to further regulate cell apoptosis, autophagy, and inflammatory responses, affecting the homeostasis and balance of ovarian tissue.133 The NF-κB and MAPK pathways are the core regulators of inflammatory response and fibrosis. The regulatory effects on the NF-κB pathway have been validated in both monomeric traditional Chinese medicine and classic formulas. Cardamom mainly comes from the ginger plant grass cardamom. In the study of cardamom induced apoptosis in ovarian cancer cells, the results showed that cardamom can effectively inhibit the abnormal activation of the NF-κB signaling pathway and mTOR pathway, reduce the release of pro-inflammatory cytokines in the ovarian microenvironment, induce G2/M phase arrest in ovarian cancer cells, and halt the cell cycle process at a specific division stage, preventing normal division and triggering the cell apoptosis program, ultimately effectively inhibiting the growth of ovarian cancer cells.134 Sophorae Flavescentis Radix can inhibit the activity of NF-κB signaling pathway, reduce the proliferation rate of ovarian cancer cells, and decrease the intensity of inflammatory response by regulating key inflammatory targets such as TNF and IL-1A.135 Yiqi Yangrong Decoction (YQYRD, Yìqì Yǎngróng Tāng, a herbal decoction tonifying qi and nourishing blood to improve ovarian microcirculation) is one of the classic tonifying formulas in traditional Chinese medicine, with the core of tonifying qi, promoting blood circulation, and strengthening the spleen and lungs. This formula can accurately target and inhibit the activation state of the NF-κB signaling pathway, significantly reduce the intensity of inflammatory reactions in ovarian tissue, and create a favorable internal environment for the normal growth and functional maintenance of ovarian cells. At the same time, YQYRD can also stimulate the formation of new blood vessels in the ovaries, increase the blood perfusion of the ovaries, provide sufficient nutrients and oxygen supply for ovarian tissues, and enhance the reserve function of the ovaries.124 These studies suggest that the NF-κB signaling pathway has potential application value in the treatment of ovarian diseases. It not only provides new potential drug options for the clinical treatment of ovarian cancer, but also opens up new ideas and directions for the prevention and treatment of ovarian aging related lesions. In the field of MAPK pathway regulation, traditional Chinese medicine active ingredients and compound formulas also have multi-level intervention effects. Pearl extract reduces oxidative stress damage and promotes cell autophagy by downregulating the expression of MAPK pathway related proteins such as ERK1/2, p38, and JNK, alleviating damage to ovarian granulosa cells and follicles, ultimately achieving effective protection of ovarian function.136 The formula of nourishing yin and tonifying yang further inhibits the abnormal activation of the MAPK signaling pathway, reduces the apoptosis rate of ovarian cells, restores the normal level of hormones in the body, and promotes the normal development of follicles by regulating the long non coding lncRNA TCONS026583-MR-421-5p-CLOCK axis, reflecting the key role of the MAPK pathway in regulating the fate of ovarian cells.137 In addition, Curcumol, as the main active ingredient of traditional Chinese medicine Curcumae Rhizoma, can effectively inhibit the proliferation and migration ability of uterine leiomyoma cells by regulating the p38MAPK/NF-κB pathway. This discovery suggests that the regulatory effect of Curcumol on the MAPK signaling pathway is highly likely to extend to ovarian related pathophysiological processes.138 After receiving signals from ROS, members of the MAPK family (ERK, p38, JNK) activate NF-κB through phosphorylation of transcription factors, leading to inflammation, and regulate the Bcl-2 family proteins to affect the mitochondrial apoptosis pathway. In the research of traditional Chinese medicine in the prevention and treatment of ovarian aging and related diseases, regulating the MAPK pathway can simultaneously improve oxidative damage and reduce cell apoptosis, providing important theoretical basis for further exploring the pathogenesis of ovarian aging. The above research results indicate that the NF-κB signaling pathway and MAPK signaling pathway play a core regulatory role in the inflammatory response system of ovarian aging and related diseases, and are key signal transduction nodes. Traditional Chinese medicine targets this pathway through “promoting blood circulation and removing blood stasis”, which can significantly reduce the degree of inflammatory response in ovarian tissue, decrease the release of inflammatory mediators, alleviate the damage of inflammation to ovarian tissue, and protect the integrity of ovarian cells. In addition, traditional Chinese medicine can promote the secretion of angiogenic factors and delay the decline of ovarian function. Nourishing Yin and Clearing Heat Method-Targeting the Nrf2/HO-1 Pathway to Combat Oxidative Stress Deficiency of kidney yin leads to internal generation of deficiency fire, which further decocts the body’s fluid essence, resulting in a decrease in the body’s antioxidant capacity and a large accumulation of reactive oxygen species in the gaps between cells and tissues. The nourishing yin and clearing heat treatment method is based on the core formula of “nourishing kidney yin to restrain excessive yang”, which can work together through multiple pathways to eliminate excessive accumulation of oxidative metabolites in the body and rebuild the dynamic balance of the body’s oxidative and antioxidant systems. Nuclear factor E2 related factor 2 (Nrf2) is a transcription factor involved in regulating antioxidant responses to protect cellular function.139 When the body is in physiological steady state, Nrf2 binds to Kelch like ECH associated protein 1 (Keap1) to form a stable complex. When responding to cellular oxidative stress, the Nrf2-Keap1 complex dissociates and Nrf2 translocates to the nucleus, which can promote the expression of antioxidant enzyme HO-1.140 The Nrf2/HO-1 signaling pathway is a key mechanism for regulating ovarian antioxidant stress, cell survival, and maintaining ovarian functional homeostasis. This pathway can regulate intracellular redox balance and deeply participate in the physiological development and daily functional maintenance of the ovary. Rehmanniae Radix Praeparata is a classic traditional Chinese medicine that nourishes kidney yin. After processing, the active ingredients in Rehmanniae Radix, such as cyclic ether terpenoid glycosides and phenylethanolic glycosides, undergo changes, enhancing the effects of tonifying the kidneys, nourishing essence, and promoting blood circulation. It can also regulate the immune inflammatory microenvironment and reduce oxidative damage. Research has shown that Rehmannia glutinosa and its processed preparations significantly improve the pathological state of ovarian dysfunction by promoting ovarian blood circulation, enhancing the proliferation ability of ovarian granulosa cells, and exerting antioxidant and anti-inflammatory effects.141 Curcumin has a protective effect on D-galactose-induced POF in mice. After treatment with curcumin, the levels of oxidative stress and cell apoptosis in mouse ovarian tissue were significantly reduced, and the expression levels of p-Akt, Nrf2, and HO-1 proteins in the curcumin group were significantly higher than those in the model group. Proving that curcumin can effectively inhibit d-gal induced oxidative stress, apoptosis, and ovarian damage through mechanisms involving the Nrf2/HO-1 and PI3K/Akt signaling pathways, it is a potential protective agent against premature ovarian failure.142 Cuscutae Semen and its processed preparations have an activating effect on the PI3K/Akt pathway, which can effectively alleviate oxidative stress-induced apoptosis of granulosa cells, promote cell survival and proliferation, and exert antioxidant effects by activating the Keap1-Nrf2/HO-1 signaling pathway. Dual pathway signaling activation provides a molecular basis for the recovery of ovarian function.143 In the field of traditional Chinese medicine formulas, Zuogui Pill can activate the Nrf2/HO-1 signaling pathway, promote the expression levels of Nrf2, HO-1, and NADPH quinone oxidoreductase 1 (NQO1), enhance the activity of antioxidant enzymes SOD and GSH-PX, reduce the MDA and ROS, and promote the proliferation of OSCs, restore the stem cell viability of rat OSCs, and prevent CTX induced ovarian aging.90 The active ingredients of Sijunzi Decoction can activate Nrf2 related signaling pathways, enhance the antioxidant capacity of ovarian cells, and slow down ovarian dysfunction induced by chemotherapy drugs.123 Traditional Chinese medicine, with its characteristic of nourishing yin, clears excess free radicals in the body, activates the Nrf2 signaling pathway, and enhances the biological activity of endogenous antioxidant enzymes. Through this series of synergistic effects, the oxidative stress damage faced by ovarian tissue can be significantly reduced, and the acceleration of cell apoptosis process can be inhibited, providing critical theoretical support and scientific basis for the field of ovarian function protection. Comprehensive Regulation-Multi Channel Interference and Microenvironment Reshaping In addition to the main treatment methods mentioned above, traditional Chinese medicine also achieves comprehensive regulation of ovarian aging through multi-channel crosstalk. In the process of ovarian aging, excessive apoptosis accelerates follicular atresia, while pyroptosis is directly associated with inflammatory response, and the two work together to cause pathological damage to ovarian granulosa cells. In terms of inhibiting cell apoptosis and pyroptosis, traditional Chinese medicine blocks the mitochondrial mediated apoptosis signaling pathway by regulating the Bcl-2/Bax ratio and inhibiting the activity of the Caspase family, ultimately achieving the goal of reducing the number of ovarian granulosa cell apoptosis. Qingxin Zishen Decoction (Qīngxīn Zīshèn Tāng, herbal compound delaying ovarian aging) can significantly increase the Bcl-2/Bax ratio, downregulate the expression of caspase-3, caspase-9, and Apaf-1, and intervene in the process of mitochondrial apoptosis.144 Moxibustion reduces apoptosis of ovarian cells in naturally aging rats by downregulating the Bax/Bcl-2 ratio.145 Meanwhile, traditional Chinese medicine can inhibit the activation of NLRP3 inflammasome, reduce the cleavage of caspase-1, thereby hindering the maturation and release of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), and reducing cell apoptosis.146 Polygonum multiflorum can regulate physiological processes such as apoptosis, necrosis, and necrosis of ovarian granulosa cells, effectively improving the functional decline of the ovary caused by aging.147 In terms of regulating the gut ovarian axis, the metabolic products of gut microbiota regulate the ovarian aging process from multiple dimensions, providing a new intervention pathway for delaying ovarian function degradation.148 At the level of immune inflammation regulation, the gut microbiota under steady-state structure can generate active substances such as short chain fatty acids through metabolism. Active ingredients in traditional Chinese medicine such as resveratrol and astragalus polysaccharides can reduce the excessive accumulation of reactive oxygen species induced by pro-inflammatory factors, alleviate chronic inflammation in the ovary, and weaken oxidative stress damage mediated by the inflammatory microenvironment, Reduce the invasion and destruction of follicular structure by inflammatory microenvironment.149,150 Research has shown that, in the intestine Desulfovibrio, Lachnoclostridium, GCA-900066575, Streptococcus and Anaerotruncus, the increase in abundance of bacteria such as Bifidobacterium can promote the release of GnRH, and short chain fatty acids derived from the gut microbiota can also affect the hypothalamic pituitary gonadal axis (HPGA) in rats.151 Therefore, at the level of endocrine and metabolic regulation, gut microbiota can participate in hormone metabolism and transformation, synergistically maintaining the signal transduction homeostasis of the hypothalamic pituitary gonadal axis, optimizing the secretion rhythm of key reproductive hormones such as estrogen and gonadotropins, and avoiding premature decline of ovarian function induced by hormone disorders. The gut microbiota can also regulate the integrity of the intestinal barrier, and the traditional Chinese medicine Cuscuta chinensis can play a protective role in the mitochondrial structure of ovarian cells, reduce apoptosis of ovarian granulosa cells, and maintain ovarian function levels.152 In the future, by transplanting microorganisms from the feces of healthy young people into the small intestine of patients or supplementing beneficial gut microbiota, ovarian aging caused by ROS, inflammation, or metabolic disorders can be effectively combated. In addition, excessive or sustained activation of endoplasmic reticulum stress (ERS) can trigger unfolded protein response (UPR), which becomes a trigger for ovarian cell apoptosis and ovarian function decline. Traditional Chinese medicine has also demonstrated unique advantages in regulating ERS and protecting ovarian function. Resveratrol, as a naturally occurring polyphenolic compound, can activate the SIRT1/NRF2 pathway, reduce the expression of endoplasmic reticulum stress markers GRP78 and CHOP, and lower the expression levels of nuclear factor kappa B (NF-κB) and pro-inflammatory cytokines interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), and interleukin-8 (IL-8), maintaining cellular protein homeostasis and achieving the goal of delaying the aging process of short-lived fish ovaries.153 There is extensive pathway crosstalk between the above mechanisms, such as PI3K/Akt phosphorylating Bad to inhibit apoptosis, activating IKK/NF-κB for anti-inflammatory purposes, and forming metabolic antagonism with AMPK at the mTOR node. However, most studies simply attribute the therapeutic effect to single pathway activation (such as Zuogui Pill and Erzhi Tiangui Decoction being reported to activate PI3K/Akt and Nrf2 simultaneously, but cross analysis is rare), which severs the intrinsic connection between pathways. At the same time, the vast majority of current research only compares traditional Chinese medicine with model groups or Western medicine, lacking a horizontal head to head comparison between different treatment methods (such as “kidney tonifying method” and “blood activating method”) in improving ovarian microcirculation, which limits the guiding significance of precise clinical prescription and medication selection. It is worth noting that the activation of some pathways has the complexity of bidirectional regulation, such as mTOR playing a positive role in follicular activation but a negative role in autophagy. Existing reviews generally ignore spatiotemporal specificity and lack exploration of the threshold for “bidirectional regulation”. Future research should focus on multi axis integrated regulation and spatiotemporal dynamic balance. In summary, traditional Chinese medicine has unique advantages in multi-target and multi pathway synergistic regulation of ovarian function. This overall regulatory effect does not act in isolation on a single link, but can be formed through treatment methods such as “tonifying the kidney, promoting blood circulation, and nourishing yin”, combined with multidimensional molecular crosstalk to form a precise regulatory network. At the level of cell proliferation and energy metabolism, traditional Chinese medicine not only activates proliferation promoting pathways such as PI3K/Akt to stimulate granulosa cell growth, but more importantly, regulates the dynamic balance between PI3K/Akt/mTOR and AMPK/mTOR at the mTOR node: it not only promotes the synthesis metabolism required for follicular development, but also initiates autophagy to clear damaged organelles under stress, maintaining the homeostasis of ovarian reserve function. In terms of regulating inflammatory response, traditional Chinese medicine can reduce the level of inflammation in ovarian tissue and alleviate the damage of inflammation to ovarian function by inhibiting inflammation related signaling pathways such as NF-κB. In response to oxidative stress, traditional Chinese medicine activates relevant antioxidant signaling pathways, such as the Nrf2/HO-1 pathway, to enhance cellular antioxidant defense and reduce oxidative damage to ovarian tissue. In terms of regulating the balance between autophagy and apoptosis, traditional Chinese medicine can precisely regulate the MAPK stress signal (p38/JNK) and PI3K/Akt related signaling pathways, such as inhibiting abnormal autophagy activation, preventing damage caused by excessive autophagy, and inhibiting the excessive transmission of apoptosis signals, reducing abnormal apoptosis of cells, and maintaining the normal quantity and function of ovarian cells. In addition, traditional Chinese medicine can improve the ovarian microenvironment, regulate intestinal microbiota homeostasis, and provide suitable conditions for the growth, development, and functional maintenance of ovarian cells. These cross regulatory mechanisms profoundly reveal the multi-target nature of ovarian aging and provide a solid molecular biology basis for the “multi-component, multi pathway” intervention strategy of traditional Chinese medicine, ultimately achieving the effect of improving ovarian function and delaying aging. Other Aspects When combined with modern assisted reproductive technologies (ART), such as in vitro fertilization-embryo transfer (IVF-ET), the application of Chinese herbal formulas demonstrates significant potential for enhancing egg quality and pregnancy rates. Studies indicate that patients undergoing ovarian function pretreatment with TCM formulas exhibit improved oocyte quantity and quality, enhanced embryonic developmental potential, and consequently, significantly elevated clinical pregnancy and live birth rates.154,155 For instance, Guilu Xian Formula (Guīlù Xiān Fāng, a yin-yang tonifying traditional Chinese medicinal formula) improved follicular count and embryo quality in older women undergoing IVF treatment.156 Moreover, TCM formulas can assist in regulating hormonal levels, optimize the endometrial environment, and enhance embryo implantation rates.157 Integrating TCM with ART in comprehensive treatment strategies enables multidimensional regulation, promoting ovarian function recovery and improved reproductive outcomes, highlighting TCM’s unique advantages and application prospects in modern reproductive medicine. Moreover, modern techniques such as network pharmacology and molecular docking provide powerful tools for elucidating interactions between key TCM components and biological targets. Network pharmacology enables systematic analysis of connections between compound constituents and disease-related protein targets, identifying key regulatory pathways and revealing molecular mechanisms underlying treatment of premature ovarian insufficiency. Molecular docking technology further validates the binding capacity of active TCM components with key proteins, supporting the molecular basis of their pharmacological effects.158 Multi-omics integrated analyses, such as combined proteomics and metabolomics studies, have helped elucidate the metabolic reprogramming and antioxidant mechanisms of TCM therapies like acupuncture in combating ovarian aging. The strategy of traditional Chinese medicine in treating ovarian aging and related diseases involves regulating the endocrine system, improving ovarian microcirculation, anti-inflammatory and antioxidant mechanisms, and regulating gut microbiota. Combined with modern assisted reproductive technology, it significantly improves ovarian function and reproductive outcomes. In the future, it is necessary to further carry out standardized clinical trials and mechanism research, clarify key active ingredients and targets of action, and promote the standardized application and international development of traditional Chinese medicine formulas. Conclusion and Future Outlook Ovarian aging, a significant challenge in female reproductive health, involves complex and diverse phenotypic manifestations, posing considerable difficulties for clinical diagnosis and treatment as well as scientific research. In recent years, continuous improvements in detection methods, particularly advances in molecular biology techniques and imaging technology, have enabled more precise identification and assessment of changes in ovarian function. Simultaneously, the widespread application of animal models has provided a robust experimental foundation for elucidating the molecular mechanisms of ovarian aging, driving in-depth mechanistic research in this field. Traditional Chinese medicine has shown promising effects in preventing and treating ovarian aging through multi-targeted, multi-pathway regulation. By modulating oxidative stress levels, suppressing excessive inflammatory responses, and maintaining the dynamic equilibrium between autophagy and apoptosis, TCM may improve the ovarian microenvironment, potentially contributing to the delay of the aging process. This multidimensional regulatory mechanism not only aligns with the complex pathological characteristics of ovarian aging but also embodies the organic integration of traditional Chinese medicine’s holistic concept with modern biomedicine. Notably, representative TCM herbs and their formulations have demonstrated clear molecular target and signaling pathway regulatory effects in basic research, while exhibiting favorable safety and efficacy in clinical applications. Particularly in assisted reproductive technologies, they have shown potential in improving ovarian reserve and improving pregnancy outcomes. However, through a systematic review and horizontal comparison of existing literature, there are still certain limitations in the study of traditional Chinese medicine and classic prescriptions in delaying ovarian aging. The current efficacy verification relies heavily on animal models, and species differences and acute intervention plans are difficult to simulate the actual clinical chronic diseases, resulting in extremely low transformation effects; Although traditional Chinese medicine formulas have multi-target advantages, their chemical composition is complex, and their synergistic and metabolic networks have not yet been elucidated. There is a lack of complete evidence chain from the molecular level to the overall pharmacodynamics, which makes their mechanism of action appear in a “black box” state. At the level of research paradigm, different studies lack unified standards in modeling methods, dosing cycles, and detection indicators, making it difficult to conduct meta-analysis and direct horizontal comparison of research results, which restricts the improvement of evidence level. At the level of clinical evaluation, existing clinical studies are mostly small sample observational trials, with no unified standards for medicinal herb base, dosage, and efficacy judgment. The results of similar studies are highly heterogeneous, and the paradigms of single component targeted research and compound overall regulation research are disconnected, without forming a fusion research system. It is particularly crucial that existing research lacks long-term safety assessment for patients with ovarian dysfunction who require long-term medication. In particular, the potential liver and kidney toxicity risks of drugs urgently need to be clarified through strict toxicological monitoring. How to balance and integrate these viewpoints has become the key to promoting the development of this field. The above limitations suggest that in the future, it is necessary to strengthen the integration of systems biology and clinical phenotype omics research, while revealing complex mechanisms of action, improving the predictive efficiency of animal experiments for clinical translation, strengthening the safety evaluation of the entire cycle, relying on omics data to construct standardized intervention plans that are in line with traditional Chinese medicine theory, and promoting evidence-based and safe development in the field. Traditional Chinese medicine has outstanding application value in the field of ovarian aging prevention and treatment due to its unique advantages of overall regulation through multiple pathways and targets. In response to existing research bottlenecks such as incomplete mechanism analysis, lack of long-term medication safety data, and inconsistent clinical evaluation systems, future research can rely on multi technology cross fusion to form a systematic research path and implement innovative research plans with operability. Integrating network pharmacology, molecular docking, and single-cell multi omics technologies, combined with an ovarian organ in vitro screening platform, systematically dismantling the interaction regulatory network between the active ingredients of the kidney tonifying and blood activating formula and key targets of ovarian aging, sorting out the internal logic of the synergistic effects of multiple components, and breaking the black box of the formula’s mechanism of action; Synchronize the inclusion of long-term toxicity dynamic monitoring indicators such as liver and kidney function, organ pathological sections, etc., standardize the safe dosage range of prescription drugs, and fill the safety data gap of long-term medication for individuals with ovarian dysfunction. Establish a multi center stratified randomized double-blind clinical trial with unified detection indicators (AMH, AFC, reproductive hormones, ovarian blood flow parameters) based on different clinical subtypes such as early-onset ovarian insufficiency and decreased ovarian reserve. Combine metabolomics to screen molecular markers corresponding to traditional Chinese medicine syndrome types, establish quantifiable syndrome differentiation standards, and form individualized traditional Chinese medicine intervention plans; Simultaneously expanding the research scenario of the combination of traditional Chinese medicine and assisted reproduction, exploring the supporting intervention strategies of traditional Chinese medicine pretreatment to improve the quality of oocytes in the elderly population and enhance the in vitro live birth rate, and broadening the clinical translation path. Based on the integration of multi-level technologies and the design of full chain experiments mentioned above, it is possible to promote the construction of a complete standardized system for the prevention and treatment of ovarian aging with traditional Chinese medicine, from basic mechanisms, toxicity evaluation to clinical evidence. Individualized diagnosis and treatment plans suitable for different reproductive aging populations can be formed, effectively improving women’s reproductive health and long-term quality of life. At the same time, a modern research paradigm for traditional Chinese medicine in reproductive diseases can be established, truly realizing the deep innovation and integration of traditional medicine and modern medicine. Funding Statement The author would like to express gratitude for the financial support provided by the Tianjin Municipal Health Commission for the Scientific Research Project on Integrated Traditional Chinese and Western Medicine (2023044). Abbreviations POI, Premature Ovarian Insufficiency; POF, Premature Ovarian Failure; DOR, Diminished Ovarian Reserve; E2, Estradiol; TCM, Traditional Chinese Medicine; HPO, Hypothalamic-pituitary-ovarian; VEGF, Vascular Endothelial Growth Factor; TGF-β, Transforming Growth Factor-β; ATP, Adenosine Triphosphate; ROS, Reactive Oxygen Species; OS, Oxidative Stress; ECM, Extracellular Matrix; NO, Nitrogen Monoxide; IL-6, Interleukin-6; TNF-α, Tumor Necrosis Factor-alpha; SASP, Senescence-Associated Secretory Phenotype; AMH, Anti-Müllerian Hormone; FSH, Follicle-Stimulating Hormone; LH, Luteinizing Hormone; INHB, Inhibin B; P4, Progesterone; Bcl-2, B-cell lymphoma/leukemia-2; Bax, Bcl-2-associated X protein; EDCs, Endocrine Disrupting Chemicals; SA-β-Gal, Senescence-Associated β-galactosidase; γ-H2A X, γ-histone H2A variant X; AFC, Antral Follicle Count; SOD, Superoxide Dismutase; GSH-Px, Glutathione peroxidase; MDA, Malondialdehyde; Caspase-3, Cysteine-dependent aspartate-specific protease-3; LC3II, Microtubule-associated protein 1 light chain 3-II; OV, Ovarian Volume; PSV, Peak Systolic Velocity; RI, Resistance Index; PPAR, Peroxisome Proliferator-Activated Receptor; IVF, In Vitro Fertilization; CTX, Cyclophosphamide; FOXO, Forkhead Box O; Foxo3a, Forkhead Box O3a; CKAP5, Cytoskeleton-associated protein 5; ELISA, Enzyme-Linked Immunosorbent Assay; CLIA, Chemiluminescence Immunoassay; HE, Hematoxylin-eosinstaining; TUNEL, Terminal deoxynucleotidyl transferase dUTP Nick End Labeling; PCR, Polymerase Chain Reaction; ER, Estrogen Receptor; PR, Progesterone Receptor; NF-κB, Nuclear factor kappa-B; IL-1β, Interleukin-1 beta; Nrf2, Nuclear factor erythroid 2-related factor 2; PRDX4, Peroxiredoxin 4; NLRP3, NLR Family Pyrin Domain Containing 3; GPX4, Phospholipid Hydroperoxide Glutathione Peroxidase; PINK1, PTEN-induced putative kinase 1; TFR, Transferrin Receptor; ACSL4, Acyl-CoA Synthetase Long-Chain Family Member 4; GSH, Glutathione; ERS, Endoplasmic reticulum stress; UPR, Unfolded Protein Response; FGSCs, Female Germline Stem Cells; EGFR, Epidermal Growth Factor Receptor; MAPK, Mitogen-activated protein kinase; mTOR, Mammalian target of rapamycin; Keap1, Kelch-like ECH-associated protein 1; OSCs, Oogonial Stem Cells; ART, Assisted Reproductive Technology; IVF-ET, In Vitro Fertilization-Embryo Transfer. Author Contributions All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References